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SUMÁRIO 
Identificação da proteína tipo-priónica Doppel em espermatozóides e o seu impacto 
na fertilidade 
O gene PRNP é responsável pela expressão da proteína priónica celular (PrPC), que, 
após sofrer uma conversão pós-tradução numa isoforma anormal e insolúvel (PrPSc), 
está associada à transmissão e à patogénese das encefalopatias espongiformes 
transmissíveis (EETs). Mais recentemente descobriu-se um outro gene, o PRND, que se 
julga ter resultado da duplicação ancestral do PRNP. O PRND é responsável pela 
expressão de uma proteína tipo priónica Doppel, que ao contrário da PrPSc, não está 
associada à propagação de EETs. A proteína Doppel é pouco expressa no cérebro, 
contrariamente à PrPC, mas é expressa no coração e, principalmente, nas células 
germinativas e de Sertoli (ratinho, ratazana, suínos, humanos, ovinos e bovinos), nas 
células de Leydig (caprinos), nas células epiteliais do epidídimo (javali, suínos), e nos 
folículos ováricos (células da granulosa). Apesar da expressão do gene PRND 
aparentemente ser constante nas células de Sertoli, a sua expressão ao nível das 
células germinativas masculinas parece variar bastante. Como tal, diferentes padrões 
de expressão deste gene podem estar associados não só à espécie, mas também à 
fertilidade ou infertilidade do macho. Por outro lado, os ratinhos fêmeas PRND-
knockout, sem expressão de Doppel, são viáveis e férteis, mas os machos são estéreis, 
o que sugere que esta proteína possa ter um papel importante na gametogénese e 
fertilidade masculina. Os machos PRND-knockout têm um comportamento sexual 
normal, com concentrações de espermatozóides próximas das normais, mas sem 
capacidade de realizar a reacção acrossómica e de fertilizar os oócitos (não penetram 
na zona pelúcida). Estudos recentes demonstram que a adição da proteína Doppel ao 
meio de capacitação aumenta a capacidade de fertilização in vitro de espermatozóides 
ovinos, reforçando a hipótese desta proteína ter funções ao nível da regulação da 
função acrossómica e da fertilidade masculina. Resultados anteriores evidenciaram 
uma associação entre os polimorfismos do gene PRND ovino e a capacidade de 
fertilização e de crio-resistência dos espermatozóides. No entanto, a função específica 
desta proteína permanece por esclarecer. 
Este trabalho tem como objectivo identificar polimorfismos no gene PRND em 
indivíduos do sexo masculino (humanos e ovinos) e comparar a qualidade e crio-
resistência dos seus espermatozóides com base nos diferentes polimorfismos 
encontrados (humano: codão 174 e 3’UTR; ovino: codão 26) através da análise da 
motilidade, vitalidade, concentração e morfologia de sémen fresco e submetido à 
criopreservação. O sémen ovino crio-preservado também foi avaliado quanto ao 
potencial mitocondrial transmembranar de espermatozóides pós-swim-up, quanto ao 
seu estadio de capacitação e quanto à sua capacidade de fertilização in vitro. A 
expressão de Doppel ovino em espermatozóides da raça Churra Galega Mirandesa 
também foi caracterizada e quantificada de acordo com o genótipo do codão 26 do 
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gene PRND através de imunofluorescência indirecta e de citometria de fluxo, usando 
anticorpos monoclonais produzidos especificamente contra este péptido. 
Os resultados deste trabalho permitiram, pela primeira vez, detectar na população 
portuguesa três polimorfismos do gene PRND humano (dois polimorfismos no codão 
174 e um 38 pares de bases 3’UTR), bem como o aumento da viabilidade do sémen 
após a descongelação em dadores com o genótipo CT do codão 174 (genótipo wild-
type) associado ao genótipo TT do polimorfismo 3’UTR (genótipo wild-type) deste 
gene. Para além disto, é possível concluir que a presença do genótipo AA do codão 26 
do gene PRND ovino melhora a crio-resistência do sémen e a produção de embriões. 
Em ovinos, estes resultados não só permitiram identificar a proteína Doppel em sémen 
fresco, através de imunofluorescência indirecta, como também permitiram a detectar, 
por citometria de fluxo, uma diminuição da expressão desta proteína em 
espermatozóides ovinos submetidos ao processo de criopreservação . 
Este trabalho permitiu ainda concluir que a identificação da proteína Doppel ovina em 
espermatozóides frescos, bem como a diminuição da sua expressão após o processo 
de criopreservação, revelam uma importante função fisiológica desta proteína na 
fertilidade masculina, abrindo novos horizontes na selecção de machos com melhor 
crio-resistência e capacidade reprodutiva, ou no desenvolvimento de tratamentos 
clínicos de infertilidade. 
 
Palavras-chave: proteína tipo priónica Doppel, espermatozóides, fertilidade, 
polimorfismo. 
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ABSTRACT 
Identification of the prion-like Doppel protein in spermatozoa and its impact in 
fertility 
The PRNP (prion protein gene) is responsible for the expression of the cellular prion 
protein (PrPC). After undergoing a post-translation conversion into an abnormal 
isoform, scrapie associated PrP (PrPSc) is involved in the transmission and pathogenesis 
of transmissible spongiform encephalopathies (TSE), including scrapie in sheep. More 
recently, Moore et al. (1999) discovered another gene whose locus is located 
downstream of that of the PRNP and named it PRND (prion-like protein gene). Also, 
PRND gene is thought to emerge from early gene duplication. This new gene is 
responsible for the expression of the downstream prion like protein, also known as 
Doppel or Dpl, which is not involved in prion propagation. Doppel is highly expressed in 
testis (Sertoli and germ cells), in the heart, in the ovaries (granulosa cells) and, unlike 
PrPC, is poorly expressed in the Central Nervous System. In PRND-knockout mice, 
females are fertile and viable, while males are infertile, suggesting a major role in male 
reproduction. Several studies have shown that the lack of Doppel can be associated 
with deficient acrosomic reaction and malformations on spermatozoa head and middle 
piece, impeding the spermatozoa to penetrate in the zona pellucida. Recent studies 
from our research group have demonstrated that capacitation medium supplemented 
with Doppel protein increases fertilization ability in sheep. Moreover, previous results 
showed an association between ram PRND gene polymorphisms and sperm 
fertilization ability and cryoresistance. However, the accurate physiological function of 
Doppel remains unclear. This work aimed to identify, characterize and quantify the 
expression of Doppel protein in ovine spermatozoa with different PRND 
polymorphisms by indirect immunofluorescence and flow cytometry. Moreover, the 
quality and cryoresistance of human and ovine sperm were compared based on 
different PRND polymorphisms, by analyzing the motility, vitality, concentration and 
morphology of fresh and thawed sperm. Ram semen was also evaluated by analyzing 
mitochondrial membrane potential of post-swim-up spermatozoa and by testing its in 
vitro fertilization ability. In conclusion, our results confirm that the AA genotype in 
codon 26 of ovine PRND gene is important for an improved semen cryoresistance and 
embryo production. Also, three human PRND polymorphisms were detected for the 
first time in male Portuguese population and an enhanced viability after thawing and 
centrifugation in density gradients of post-thawed sperm observed in male donors 
carrying CT genotype of codon 174 polymorphisms linked to TT genotype of 3’UTR of 
human PRND gene. Furthermore, the identification of Doppel protein in ovine semen 
and its decrease expression after the frozen-thawed process strongly suggests an 
important physiological function in male fertility. 
 
Keywords: prion-like protein Doppel, spermatozoa, fertility, polymorphism. 
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1. INTRODUCTION 
1.1. Historical approach to prion diseases and Doppel 
The first prion disease in humans, named Creutzfeldt-Jakob disease (CJD), was 
described in 1929 by Creutzfeldt and Jakob, who depicted a progressive dementia 
associated with motion abnormalities, extensive vacuolation and astrocytic gliosis in 
the brain (Creutzleldt, 1920). Kuru was only discovered in the mid-1950s by Carlton 
Gajdusek who described it as an endemic disease among the Fore tribe, in New 
Guinea, and it was manifested as progressive gait ataxia in combination with abnormal 
behavior and a relatively rapid progression to death. This disease affected mostly 
women and children since during the cannibalistic feast the men could choose which 
body parts they wanted to eat, leaving the remains, including infectious brains, to the 
women and children (Hadlow, 1999; Mastrianni, 2004). 
William Hadlow, a veterinarian-scientist, was the first to notice that Kuru and Scrapie, 
a transmissible disease of sheep, exhibited similar pathological features (Hadlow, 
2008). This discovery led to success of transmission experiments of Kuru and CJD to 
chimpanzees, demonstrating they both carry the same spongiform pathology. Since 
this discovery, several other members of the family of transmissible spongiform 
encephalopathies (TSEs) of both mammals and humans have been discovered 
(Gajdusek et al., 1966; Mastrianni, 2004). Later on, the discovery of new mechanisms 
for the origin and dissemination of infectious diseases, including prion diseases, 
granted Carlton Gajdusek a Nobel Prize in 1976 (Gajdusek, 1977; Mastrianni, 2004). 
Until the mid-1990s, TSEs were considered to result from a ‘slow virus’ infection that 
could be inactive for years prior to manifestation of disease. However, neither viral 
particles nor nucleic acids were detected to support a viral theory (Prusiner, 1998). 
Instead, several evidences of an abnormal isoform of prion protein (PrPSc) appeared as 
the cause of TSEs, which granted Stanley Prusiner the second TSE-related Nobel Prize 
in 1997 for the discovery of an infectious particle responsible for transmission of TSEs: 
the prion protein (Prusiner, 1998). The scientific investigation of the transmission of 
prion protein diseases only began after the molecular genetic lesion had been 
identified. The PRNP gene, responsible for PrPC expression, was firstly identified in 
families with prion disease by positional cloning or through the purification and 
sequencing of PrPC in amyloid plaques, before transmissibility was verified (Prusiner et 
al., 1998). 
According to the ‘protein-only’ hypothesis, prions are infectious protein particles and 
they are the major contributing agents of TSEs in mammals. A hallmark of this type of 
pathology is the conversion of the normal cellular prion protein isoform (PrPC), 
expressed by the PRNP, into a scrapie-associated isoform (PrPSc) with an abnormal 
conformation (Prusiner et al., 1998). The etiology of TSEs can be sporadic, suggesting 
an inefficient degradation of PrPC by the ubiquitin-proteasome system, dominantly 
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inherited, based in mutations within the PRNP gene that can lead to a spontaneous 
conversion of PrPC to PrPSc, and acquired by infectious of previous contaminated 
tissues. The most common TSEs in humans and other mammals are briefly described in 
Table 1 (Prusiner et al., 1998; Mastrianni, 2004; Fornai et al., 2006; Colby and Prusiner, 
2011). 
 
Table 1 – Prion diseases in humans and other mammals (adapted from Mastrianni (2004) and Colby and Prusiner 
(2011)) 
Disease Host Etiology Mechanism of pathogenesis 
Kuru Human Acquired 
Ritualistic cannibalism, consumption or direct 
contact with human brain infected with Kuru 
iCJD Human Acquired 
hGH, dura mater grafts, corneal transplants, β-
HCG, neurosurgical procedures, medical 
equipment 
vCJD Human Acquired Consumption of contaminated bovine products 
Scrapie Sheep Acquired Infection 
BSE Cattle 
Acquired or 
sporadic 
Infection 
TME Mink Acquired Infection with sheep and cattle prions 
CWD Mule deer, elk Acquired Infection 
FSE Cat Acquired 
Infection with prion-contaminated bovine 
tissues or MBM 
fCJD Human Inherited Germline point mutations in PRNP gene 
GSS Human Inherited Germline point mutations in PRNP gene 
FFI Human Inherited Germline point mutations in PRNP gene 
sCJD Human Sporadic 
Somatic mutation, spontaneous conformation 
change from PrPC to PrPSc 
sFI Human Sporadic 
Somatic mutation, spontaneous conformation 
change from PrPC to PrPSc 
iCJD – iatrogenic Creutzfeldt-Jakob disease; vCJD – new variant Creutzfeldt-Jakob disease; BSE – bovine spongiform 
encephalopathy; TME – transmissible mink encephalopathy; CWD – chronic wasting disease; FSE - feline spongiform 
encephalopathy; fCJD – familial Creutzfeldt-Jakob disease; GSS - Gerstmann-Sträussler-Scheinker disease; FFI – fatal 
familial insomnia; sCJD – sporadic Creutzfeldt-Jakob disease; sFI – sporadic fatal insomnia. 
 
The classic TSE, also known as scrapie, has been observed in European sheep for more 
than 200 years, whereas bovine spongiform encephalopathy (BSE) in cattle seems to 
be associated with modern agricultural practices (1986). More recently, a new variant 
of CJD (vCJD) was transmitted to humans by ingestion of BSE-contaminated food 
products (Hil et al., 1997; Scott et al., 1999; Casalone et al., 2004), meaning that the 
“species barrier” between cattle, sheep, human and other mammalian species was 
crossed by the biological properties of BSE, also known as Human Mad Cow disease, 
raising considerable concern for human health. Given this, the European Community 
(EC) started a selection program based on the known genotypes of PRNP that have 
been associated with different grades of susceptibility to scrapie. The identification of 
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4 different single nucleotide mutations in the PRNP coding region and their linkage to 
different resistance to scrapie allowed the elaboration of a “table of susceptibility”, 
which includes 5 groups of grades of resistance (R1-R5), briefly described in Table 2. In 
2003, the EC (decision nº 100/2003) implemented this selection program which aims 
to eradicate scrapie from its member states and to create disease-resistant animals, 
allowing the introduction of scrapie-resistant genes and eliminating the most 
susceptible ones, with the ram as a major selection target. With respect to PRNP 
(Table 2), three genotypes were not represented: ARR/ARH, ARH/ARH and VRQ/VRQ 
(Gama et al., 2006). However, within small population, such strategy might drastically 
decrease valuable genetic diversity due to intensive selective breeding for disease-
resistant genotypes (Ehling et al., 2006; Gama et al., 2006), leading to undesirable 
consequences which might include a blind selection for other genes linked to 
reproduction and/or to PRNP, like PRND (prion-like Doppel protein gene) and PRNT 
(prion protein testis-specific gene) (Lipsky et al., 2008; Mesquita et al., 2010). 
 
Table 2 – Sheep PRNP polymorphisms in codon 136, 154 and 171 and the scrapie-associated susceptibility grades 
(adapted from Mesquita et al. (2010)) 
Susceptibility R1 R2 R3 R4 R5 
PRNP 
genotype 
ARR ARR AHQ ARR AHQ AHQ ARQ ARQ ARR AHQ ARQ ARH 
ARR AHQ AHQ ARQ ARQ ARH ARQ ARH VQR VQR VQR VQR 
R1 to R5: scrapie susceptibility groups (from less to more susceptible) corresponding to each PRND genotype. 
 
Although PRNP was originally considered to be unique within the mammalian genome, 
it has been shown to have a paralogue: the downstream prion-like protein gene, also 
called prion-like Doppel protein gene (PRND). When PRNP was knocked out in mouse 
(PRNP0/0), no phenotypical alterations were observed, supporting a non-critical 
function of PRNP or at least a redundancy of its function by another protein. Yet, ever 
since other lines of PRNP0/0 have been created, displaying a distinct ataxic phenotype 
attributed not to the loss of function of PrPC but to the deletion of variably lengthened 
segments of DNA, resulting in enhanced expression of a downstream protein. This 
protein was named Doppel (or Dpl) and is expressed by the PRND gene (Moore et al., 
1999). Latter on other family genes (PRNT and shadow of prion protein gene – SPRN) 
were identified, contributing together to the so called prion genetic complex (Premzl 
and Gamulin, 2007; Pimenta et al., 2012b). 
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1.2. Prion genetic complex 
The PRN genomic locus comprehends three genes: PRND, PRNP and PRNT, and they 
can be found on chromosomes 10 and 22, in sheep and human, respectively (Lampo et 
al., 2007). The SPRN gene is not part of this genomic locus (Lampo et al., 2007; Watts 
and Westaway, 2007; Pimenta et al., 2011). PRND contributes, along with PRNP, PRNT 
and SPRN genes, to the “prion genetic complex”. This four prion and prion-like genes 
show similar gene organizations, although they exhibit different expression patterns 
and have distinct biological functions (Premzl and Gamulin, 2007; Pimenta et al., 
2012b). 
 
1.2.1. PRNP 
The PRNP is a highly conserved housekeeping gene that has been described in fish 
(Premzl and Gamulin, 2007) and several eutherian species, like human, sheep, mouse 
(Lee et al., 1998), bovine (Hills et al., 2001) and hamster (Li and Bolton, 1997). PRNP 
gene has three exons in mouse, sheep (Lee et al., 1998), rat (Saeki et al., 1996) and 
bovine (Hills et al., 2001), with the first two exons encoding the 5’UTR of mRNA, but 
only two exons in human (Lee et al., 1998), with the first exon encoding the 5’UTR 
region. In placental mammals, PRNP promoters are all rich in cytosine-phosphate-
guanine (CpG) islands and lack TATA box, despite some differences in gene structure 
and regulation of gene expression among species. 
PRNP is expressed mostly within glia and neuronal synapses in the central nervous 
system (CNS), although it could be found in a broad range of vertebrate tissues, such 
as spleen, lymph nodes, lungs, heart, kidneys, muscle, mammary glands and both male 
and female gonads (Miranda et al., 2011). This gene is clearly upregulated in the CNS 
at both fetal and adult stages, with PrPC (Fig. 1) mainly localized to synapse 
membranes (Herms et al., 1999). However, PRNP mRNA can also be found in adult 
epididymis at levels almost as high as in the brain (Makrinou et al., 2002). 
 
1.2.2. SPRN 
The shadow of prion protein gene, also named SPRN, encodes the Shadoo protein  and 
is located outside PRN genomic locus, more precisely in chromosomes 7, 10 and 22, in 
mice, humans and sheep, respectively (Lampo et al., 2007; Watts and Westaway, 
2007). It comprises two exons with the open reading frame (ORF) contained within a 
single exon, as PRNP and PRND. SPRN has been observed in eutherian and fish (Premzl 
et al., 2003; Watts and Westaway, 2007). 
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In sheep, Shadoo expression presented high levels in cerebrum and in Purkinje cells of 
cerebellum, and low levels in testis, lymph node, jejunum, ileum, colon and rectum 
(Lampo et al., 2007). In immunohistochemistry assays, Shadoo was immunopositive in 
the cerebrum, hippocampus, pituitary gland, medulla oblongata, thalamus and 
hypothalamus. Remarkably, a typical granular pattern was seen in most of the tested 
brain tissues, which might indicate that Shadoo is primarily expressed at synapses 
(Lampo et al., 2007). 
 
1.2.3. PRNT 
The prion protein testis-specific gene (PRNT) is located 3 and 6 kb 3’ downstream of 
PRND in human (Makrinou et al., 2002) and cattle (Kocer et al., 2007), respectively. 
This gene probably emerged due a duplication event during eutherian species 
divergence, since is present among other species. It has two exons in primates, bovine, 
horse and dog (Makrinou et al., 2002; Harrison et al., 2010). PRNT encodes the testis-
specific prion protein-like (Prt). 
PRNT gene promoters do not include CpG islands, which suggests a tissue-specific 
expression (Makrinou et al., 2002; Premzl and Gamulin, 2007). PRNT expression in 
caprine and human tissues was studied only at mRNA level (Makrinou et al., 2002; 
Kocer et al., 2007). Recently, Pimenta et al. (2012b) were able to found ovine Prt, by 
indirect immunofluorescence, in sperm head apical ridge subdomain before and after 
in vitro capacitation, and by immunohistochemistry in spermatogonias, spermatocytes, 
spermatids and spermatozoa, indicating a function during ram spermatogenesis. 
Moreover, results showed that ovine Prt was found in seminiferous tubules, along the 
developing stages of germinal cells (spermatogonia, spermatocytes, spermatids and 
also in spermatozoa). Only caprine PRNT revealed a low and irregular expression 
pattern at different development stages, suggesting a different PRNT expression 
between species (Kocer et al., 2007). 
 
1.2.4. PRND 
PRND is located 20 kb (humans; Makrinou et al., 2002), 16.8 kb (sheep; Comincini et 
al., 2001), 16 kb (mouse; Moore et al., 1999) and 52 kb (cattle; Essalmani et al., 2002). 
Doppel has a significant homology to the C-terminal segment of PrPC, so it was 
proposed that PRND and PRNP arose by an early gene duplication event of an ancestral 
PRN gene (Moore et al., 1999). It contains two exons in sheep, cattle (Comincini et al., 
2001) and goat (Uboldi et al., 2005), and three exons in mouse and human (Moore et 
al., 1999). 
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PRND gene presents characteristics of a housekeeping gene, though Doppel is mainly 
expressed in male genital tract, suggesting that PRND transcription and/or translation 
is probably submitted to a tight regulation (Comincini et al., 2001). PRND mRNA was 
found to be expressed in the spleen, suggesting a potential role for Doppel in lymphoid 
cells (Li et al., 2000); however, the immune system appeared to be normally developed 
in PRND0/0 mice (Behrens et al., 2002). Doppel can be found in both Sertoli and germ 
cells in mice, rat, swine (Behrens et al., 2002; Serres et al., 2006), humans (Peoc’h et 
al., 2002), ovine (Espenes et al., 2005) and bovine (Rondena et al., 2005), in goat 
Leydig cells (Kocer et al., 2007) and in boar epididymis epithelial cells (Serres et al., 
2006), which allied to the sterility presented in PRND0/0 mice (Behrens et al., 2002) 
suggests an important physiological role on male fertility (Moore et al., 1999; 
Silverman et al., 2000; Tranulis et al., 2001; Peoc’h et al., 2002; Rondena et al., 2005; 
Serres et al., 2006; Kocer et al., 2007). Doppel is permanently expressed in Sertoli cells, 
but its expression in the germ cells can vary accordingly to species. In ovine, Doppel 
can be detected in the seminiferous epithelium in the final stages of spermatogenesis, 
but it was not always detected in the ejaculated spermatozoa. On the other hand, 
bovine and human Doppel was found to be expressed in the ejaculated spermatozoa 
(Espenes et al., 2005; Rondena et al., 2005; Serres et al., 2006; Kocer et al., 2007). This 
may suggest an expression level in ovine smaller than the detection limit of the 
methods used so far. 
  
Fig. 1 – Murine Doppel and PrP
C
 secondary structure elements (adapted from Pimenta (2013)) 
22 
 
1.3. Prion and Prion-like proteins: structural and biochemical 
properties 
1.3.1. PrPC 
The cellular prion protein (PrPC) is a non-pathogenic glycoprotein attached to the cell 
surface by a GPI anchor that is translated as a 253 and 256 amino acid protein in 
human and sheep, respectively. The PrPC has a long and flexible N-terminal tail, three 
α-helices and two stranded antiparallel β-sheet (Mo et al., 2001). This protein can 
present at least three distinct topological orientations: the fully extracellular (PrPC) 
form (Hölscher et al., 2001), and two transmembrane isoforms with opposite sequence 
orientations (NtmPrP and CtmPrP) (Hegde et al., 1998; Nicolas et al., 2009). 
The normal physiological function of PrPC remains uncertain, although there is some 
evidence that it may have a protective effect against neuronal damages. More 
precisely, PrPC is upregulated following ischemic brain damage, in both human and 
mice (McLennan et al., 2004; Weise et al., 2004), and has a neuroprotective activity 
against apoptosis in vivo (Nishida et al., 1999; Moore et al., 2001; Rossi et al., 2001; 
Westergard et al., 2007). Another hypothesis is that PrPC could also be a signal 
transduction protein since it activates in vitro a signaling pathway and targets the MAP 
kinases ERK1/2 of both neuronal and non-neuronal cells. 
The scrapie-associated prion protein isoform (PrPSc) is derived from the PrPC by a 
posttranslational process involving a profound conformation change. Although these 
two isoforms share the same amino acid sequence, their biochemical and biophysical 
properties are remarkably different. PrPC is predominantly α-helical (Mo et al., 2001), 
soluble in non-denaturing detergents and completely sensitive do proteinase-K 
digestion. On the other hand, PrPSc biochemical structure has more than 40% of β-
sheet, is insoluble in non-denaturing detergents, and has a relative resistance to 
proteinase-K (Mastrianni, 2004). 
 
1.3.2. Shadoo 
Shadoo (the Japanese word for shadow) is a hypothetical GPI-anchored protein that 
exhibits homology to the N-terminus of PrPC. The expression of this prion-like protein 
stimulates a PrPC-like neuroprotective activity and several other biochemical and cell 
biological properties also exhibited by PrPC, although is low in cerebellar granular 
neurons containing PrPC, high in PrPC-deficient dendritic processes  and absent during 
prion infections, suggesting an interference of PrPSc in the physiological protective 
activity of Shadoo (Watts et al., 2007). 
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1.3.3. Prt 
Human Prt and PrPC only have 44% similarity and 30% identity, whereas human PRND 
and PRNT only have 50% similarity and 42% identity. In bovine, PRNT encodes a 55 
amino acid N-terminally truncated protein and has only 55% identity to its human 
counterpart. No signal peptides were predicted for Prt, suggesting that Prt could be an 
intracellular protein (Kocer et al., 2007; Premzl and Gamulin, 2007). The accurate 
biological function of this prion protein-like remains unclear, although Pimenta et al. 
(2012b) and Pimenta (2013) suggests a role for Prt protein in the ram reproductive 
physiology, namely in the fertilization process. 
 
1.3.4. Doppel 
As referred, Doppel was firstly recognized due to an ataxic phenotype of a PRNP0/0 
mice line, and direct expression of Doppel in PRNP0/0 mice have been shown to 
produce ataxia and loss of Purkinje cells at 6-12 months of age. However, no 
pathological characteristics of prion diseases were observed. Even in neuronal tissues 
of PRNP0/0 mice, the absence of Doppel does not affect disease progression of 
experimental prion pathogenesis (Behrens et al., 2001; Moore et al., 2001). There is 
some evidence suggesting that Doppel may be toxic to neurons, but no mutations of 
PRND have yet been linked to any inherited prion disease, nor there is evidence of high 
expression of Doppel in patients with PrP-induced diseases (Mead et al., 2000; Behrens 
et al., 2001; Cui et al., 2003).  Like PrPC, Doppel is a GPI anchored glycoprotein 
structured by a 3 α-helices and 2 β-sheets, although it has only 25% amino acid 
similarity to PrPC and lacks the distinctive PrPC repeats and the hydrophobic domain 
(Silverman et al., 2000). 
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1.4. Prion and prion-like proteins: impact in fertility 
1.4.1. PrPC 
In situ hybridization analysis indicates that PRNP mRNA in adult testis can be elevated 
to levels almost as high as in the brain, showing positive signals in spermatogenic cells, 
but not in somatic cells (Sertoli and Leydig cells) (Makrinou et al., 2002; Schneider et 
al., 2003). The signals were observed moderately in spermatogonia and strongly in 
spermatocytes and round spermatids, but not in elongated spermatids and 
spermatozoa, indicating that PrPC may have a possible role in germ cell differentiation 
during mammal spermatogenesis (Fujisawa et al., 2004). PrPC can also have an 
important function in regulation of spermatogenesis oxidative stress, as a cooper 
binding protein (Brown et al., 1997a and b). In the ovine reproductive tract, Gatti et al. 
(2002) showed that different PrPC isoforms were present in the male genital tract 
fluids. Moreover these isoforms were secreted by the epididymal epithelium. 
 
1.4.2. Shadoo 
Young et al. (2011) created a mouse lineage carrying a transgenic SPRN (SPRN-LacZ) 
and was able to verify that Shadoo was expressed in Leydig cells, suggesting an 
important function in the development of the male reproductive system, and in the 
granulosa cells of the developing follicle, reinforcing the previous hypothesis of an 
association between SPRN and fertility, demanding further investigation. 
 
1.4.3. Prt 
Prior to the studies of Pimenta et al. (2012b), Prt expression pattern was studied only 
at mRNA level in human, caprine and ovine (Makrinou et al., 2002; Kocer et al., 2007). 
The three human Prt isoforms were only detected in adult testis, more precisely in 
Sertoli, Leydig and germ cells, revealing an important role in sperm production 
(Makrinou et al., 2002). Also, Prt isoforms were not detected in any of the human fetal 
tissues analyzed (Makrinou et al., 2002). This results indicate that Prt function is only 
required at a post-pubertal stage, when the above-mentioned cell types are actively 
involved in the production of male sex hormones and sperm. More recently, Pimenta 
et al. (2012b), based on immunofluorescence and immunohistochemistry assays, were 
able to report for the first time the location of ovine Prt in spermatozoa, confirming 
that ovine PRNT gene is effectively translated. Furthermore Pimenta et al. (2013a) 
showed that by blocking Prt function through the addition of an anti-Prt polyclonal 
antibody the fertilization rate was decreased. Taken together, these observations 
suggest that Prt could exert its main function in the fertilization process, potentially in 
the initial steps due to its location in the acrosome of ovine spermatozoa. 
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1.4.4. Doppel 
Behrens et al. (2002) created homozygous mutant mice lacking Doppel (PRND0/0) from 
intercrossed heterozygous mice carrying the mutated PRND allele (PRND+/0) and verify 
that both male and female PRND0/0 mice displayed normal growth and survival, 
demonstrating the absence of obvious detrimental effects of Doppel deficiency on 
development and growth. Doppel was present in the testis of PRND+/+ and PRND+/0, 
but it was absent in homozygous mutants. Summarizing, PRND0/0 females appear to be 
viable and fertile, and PRND0/0 males were infertile (Behrens et al., 2002; Peoc’h et al., 
2002; Paisley et al., 2004; Espenes et al., 2005). 
Although PRND0/0 male mice presented normal sexual behavior with normal number of 
copulation plugs and reduced or normal sperm concentrations, the sperm showed 
malformed spermatids and appeared to be unable to undergo the normal acrosome 
reaction, resulting in the inability to penetrate the zona pellucida of the oocyte 
(Behrens et al., 2002; Paisley et al., 2004). Yet, partially mechanical dissection of zona 
pellucida could restore in vitro fertilization ability. Since Doppel is a highly glycosylated 
protein (Moore et al., 1999; Silverman et al., 2000), and oligosaccharides have been 
implicated in signaling for the acrosome reaction (Wassarman and Litscher, 2001), it is 
plausible that Doppel could be directly involved in sperm-egg interaction (Behrens et 
al., 2002). 
The number of spermatozoa in the cauda epididymis of PRND0/0 males was reduced in 
50%, when compared to wild-type controls. Also the motility of mutant sperm was 
significantly decreased, suggesting a spermatogenesis defect (Behrens et al., 2002). In 
sheep, Espenes et al., (2005) detected the transient presence of Doppel in the final 
stages of spermiogenesis, which points to an important role of this protein in the final 
remodeling of spermatids prior to their release into the seminiferous lumen. Although 
Doppel was not detected in the seminiferous tubules of PRND0/0 mice, histological 
examination revealed normal distribution and numbers of spermatogonia and 
spermatocytes. However, the transformation of round spermatids into testicular 
spermatozoa was abnormal in Doppel-deficient testis. Moreover, the expression of 
maturation stage-specific genes in testis appears to be normal, despite the absence of 
Doppel (Behrens et al., 2002). 
Serres et al. (2006) hypothesized that Doppel could be acquired during the passage of 
maturing spermatozoa through the epididymis, as it has been described for other GPI 
proteins anchored to spermatozoa, suggesting a possible epididymis origin of Doppel. 
Interestingly, haploid spermatozoa lacking Doppel gene (PRND0) are perfectly fertile 
when generated in the context of a heterozygous (PRND+/0) mouse. This might due to 
the fact that sperms spends much of the maturation time in the form of syncytia 
where all maturating cells are connected to each other by cytoplasmic bridges, 
allowing Doppel protein to be transferred from PRND+ to PRND0 spermatids and rescue 
fertility (Behrens et al., 2002). Pimenta et al. (2012a) recently demonstrated that ovine 
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sperm supplementation with recombinant Doppel protein during in vitro capacitation 
significantly improved spermatozoa motility, vigor, viability and fertilization rate, 
suggesting a major role in ovine sperm capacitation and in the consequent fertilization 
process. 
Behrens et al. (2002) concluded that Doppel (Fig. 2) deficiency did not interfere with 
mice embryonic and postnatal development. However, Paisley et al. (2004) used 
different PRND0/0 mouse lines with a different genetic background and demonstrated 
that Doppel can also be required for sperm to contribute to embryonic development 
beyond the morulae stage. Also, high levels of damaged DNA were observed, which 
indicates a possible involvement in protection from oxidative stress. In fact, it has been 
demonstrated that ROS can modulate fertility: increasing ROS can reduce sperm 
motility and performance (Whittington et al., 1999). 
A possible association between PRND gene polymorphisms and ram sperm traits, 
freezability and fertility was recently suggested by Baptista et al. (2008) and Pereira et 
al. (2009). A multiple restriction fragment – single-strand conformation polymorphism 
(MRF-SSCP) analysis of genomic DNA of some Portuguese ovine breeds allowed the 
identification of a polymorphism in codon 26 of PRND gene. A synonymous 
substitution G→A was revealed and gave rise to three genotypes: GG (wild-type 
homozygous), GA (mutant heterozygous) and AA (rare mutant homozygous). Although 
AA genotype rams were not analyzed, the results showed an improved concentration 
for the ovine semen carrying the GA genotype, over GG genotype, as well as an 
improvement in sperm fresh vitality and a decrease of spermatozoa head anomalies 
after thawing. Despite being a synonymous substitution, it can affect protein folding 
and its activity/substrate specificity (Kimchi-Sarfaty et al., 2007), and the presence of 
the allele A in codon 26 genotype might improve fertility in GA animals. In human, 
Peoc’h et al. (2002) investigated whether the polymorphism at codons 26 (T26M), 56 
(P56L) and 174 (T174M) of human PRND would affect the processing the Doppel 
protein. There were no major abnormalities in cellular trafficking of the human Doppel 
(HuDpl; Fig. 2) and no cell toxicity effect resulting from each polymorphism in 
comparison to the wild-type HuDpl. However, it remains unclear whether these 
polymorphisms could modify structural and/or functional aspects of Doppel, affecting 
spermatogenesis and/or spermatozoa motility. 
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Fig. 2 – Comparison between ovine (blue) and human (brown) Doppel tertiary structures (adapted from Pimenta 
(2013)) 
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1.5. Objectives 
This work aimed to identify polymorphisms in PRND gene of male individuals (human 
and rams) and compare the quality and cryoresistance of their sperm based on those 
identified polymorphisms (human: in codon 174 and 3’UTR; ovine: codon 26), by 
analyzing the motility, vitality, concentration and morphology of fresh and frozen-
thawed semen. Ram semen quality and cryoresistance was also evaluated by analyzing 
mitochondrial membrane potential of post-swim-up semen and by testing its in vitro 
fertilization ability. Additionally, ovine Doppel expression was characterized and 
quantified in semen from Churra Galega Mirandesa rams classified accordingly to 
codon 26 genotype of PRND gene. This evaluation was performed by indirect 
immunofluorescence and by flow cytometry using monoclonal antibodies produced 
specifically against this peptide. 
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2. MATERIALS AND METHODS 
This work was carried out from September 2012 to April 2014 in the National Institute 
of Agriculture and Veterinary Research (INIAV, I.P., Santarém, Portugal), in close 
cooperation with the Center of Medical Reproduction of British Hospital Lisbon XXI, 
(Lisbon, Portugal) and with the Hygiene and Tropical Medicine Institute (IHMT, Lisbon, 
Portugal). 
 
2.1. Production of monoclonal antibodies against ovine Doppel 
2.1.1. Mouse immunization 
The ovine 178 aa Doppel peptide (accession number NP_001009261, GenPept) was 
obtained from CASLO Laboratory Aps (Denmark) showing >95% purity, and used 
without further purification. Three five to six week-old female BALC/c mice were 
injected intraperitoneally with 60-80 µg of purified ovine Doppel emulsified in 
incomplete Freund’s adjuvant (Sigma-Aldrich, USA) and boosted monthly (adapted 
from Pimenta et al. (2012b)). After 4 immunizations, blood samples were obtained 
from mice for serum titer determination by enzyme-linked immunosorbent assay 
(ELISA). 
 
2.1.2. ELISA 
Antibody responses generated against ovine Doppel were measured by ELISA (adapted 
from Pimenta et al (2012b)). Briefly, Costar 3690 96-well ELISA plate were coated with 
0.1 µg/well or with 2 µg/well (ovine Doppel) overnight at 4oC, followed by a four time 
wash and then blocked with 100 µL/well of 5% (w/v) skim milk (Difco, USA) in T-TBS 
(0.05% (v/v) Tween-20) for 1 h at 37oC. 
The ELISA plate was washed four times with T-TBS. Afterwards the plate was incubated 
with serum from immunized mice and from non-immunized control mouse for 1 h at 
37oC, followed by another four time wash with TBS-T. 
Anti-mouse polyvalent immunoglobulin-alkaline phosphatase (AP) antibody (Sigma-
Aldrich, USA), 100 µL/well of diluted 1:100, 1:500 and 1:1000 in PBS were added and 
incubated for 1 h at 37oC. The p-Nitrophenyl Phosphate (p-NPP; J. T. Baker, The 
Netherlands) was added and incubated in the dark for 30 min at room temperature. 
Then the analysis of the AP activity was read on an ELISA plate reader (Dynex 
Technologies, USA) at an excitation wavelength of 405 nm and analyzed with 
Microplate Manager 4.0 software (Bio-Rad, USA). 
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2.1.3. Monoclonal screening for antibody producing hybridomas 
Once the titer was high enough, cell fusion was performed. Three days before cell 
fusion, mice were boosted with ovine Doppel and then euthanized by cervical 
dislocation for spleen removal. Also, mice total blood was also collected in order to 
obtain antiserum. 
Spleen cells were fused with myeloma cells Sp2/0-Ag14 during culture in DMEM 
(Sigma-Aldrich, USA) with HAT media supplement (Sigma-Aldrich, USA). Only hybrids 
between myeloma and spleen cells are capable of surviving in HAT supplemented 
medium. 
At day 10, supernatants of wells containing hybridomas were tested by ELISA. Assay 
plate was prepared as described previously including a well with PBS (no antigen) to 
check for non-specific reactions of the primary antibody (antiserum). Four different 
controls were performed against the Doppel protein: a positive control with antiserum 
diluted 1:1000, and three negative controls (antiserum with no secondary antibody; no 
antiserum with secondary antibody; no antiserum or secondary antibody). Hybridoma 
supernatant was used as primary antibody. 
The hybridomas selected by ELISA were expanded to 24-well plates and subsequently 
to 25 cm2 tissue culture flasks. Supernatants (as primary antibody) were tested against 
by ELISA and also by Western Blotting. For storage, supernatants were filtered with a 
0.22 µm syringe filter (Carl Roth GmbH + Co. KG, Germany) and kept at -20oC. 
 
2.2. Genetic analysis 
In the present study, DNA samples from 10 rams from Churra Galega Mirandesa breed 
and from 29 men were analyzed for PRND polymorphisms screening. 
 
2.2.1. DNA extraction and amplification 
For the ram samples, DNA was extracted from blood using the Spin Protocol of DNA 
Purification Kit from Blood or Body Fluids (QIAmp®, Qiagen, Germany). The PRND 
coding region (exon 2) was amplified by PCR using specific primers (DOP1-F: 5’-
TCCGACACAATGAGGAAACATCTGGG-3’ and DOP1-R: 5’-
TTGATCTCTGTGGCTGCCAACTTGC-3’) designed based on the published ovine PRND 
gene sequence (accession number AF394223 GenBank) as in Pereira et al. (2009). 
For the human samples, DNA was extracted from semen using an adapted protocol of 
Puregene DNA Purification Kit: DNA Purification Protocol for 50 µL Human Blood 
Strains (Puregene, Gentra Systems Inc., USA), using 100 µL of human semen and no 
glycogen. The human PRND coding region (accession number NM_012409.2, GenBank) 
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was amplified by PCR using specific primers (HuDpl72-F 5’-
AGTTAACCCTGCACAACCCAA-3’ and HuDpl73-R 5’-GCACCT TCAGAACACGCGT-3’) as in 
Schröder et al. (2001). 
PCR reactions were performed for both species in a UNOII thermocycler (Biometra, 
Germany) according to the following conditions: 50 ng of genomic DNA, 16 pmol of 
each primer, 1.25 U of NZYTaq DNA polymerase (Nzytech, Portugal), 1X reaction buffer 
(67mM Tris-HCl, pH 8.8, 16 mM (NH4)2SO4, 0.01% Tween-20), 2 mM of MgCl2, 200 µM 
of each dNTP, for a final volume of 25 µL. The amplification included an initial 
denaturation step at 95oC for 5 min, followed by 30 cycles of denaturation at 95oC for 
30 s, annealing at 58oC (ram samples) or 59oC (human samples) for 30 s, and extension 
at 72oC for 30 s, followed by a final extension at 72oC for 5 min. The resulting 
amplification fragment of both ram (579 bp) and human (805 bp) was confirmed by 
electrophoresis on a 2% agarose gel containing 0.14 µg mL-1 of ethidium bromide 
(Qbiogene, USA), adapted from Pereira et al. (2009) and Schröder et al. (2001), 
respectively. 
 
2.2.2. Polymorphism analysis by MRF-SSCP 
For the ram samples, the amplified 579 bp fragment was analyzed by multiple 
restriction fragment – single-strand conformation polymorphism (MRF-SSCP): 7.5-9.0 
µL of the amplification products were digested with 3 U of EcoR V restriction enzyme 
(Thermo Scientific, USA) at 37oC for 18h (Pereira et al., 2009). For the human samples, 
the amplified 805 bp fragment were also analyzed by MRF-SSCP but with the following 
alterations: 5.0-10.0 µL of amplification products were digested with 3 U of Bgl I 
restriction enzyme (Metabion, Germany), adapted from Peoc’h et al. (2000). 22.5 µL  
of a denaturing solution (Table 17, Annex I) were added to the digestion products, for 
both species, as in Pereira et al. (2009). 
The samples were heat-denatured at 95oC for 5 min, immediately chilled at 0oC and 
the total volume was loaded into a 13.6% polyacrylamide gel with 2.5% crosslinking. 
The polyacrylamide gel ran at 30 W for 4h22 (3000 Vh) at 20oC, and at 30 W for 4h23 
(3000 Vh) at 15oC, for ram and human samples, respectively. Both polyacrylamide gel 
were ran in a DCode TM Universal Mutation Detection System (Bio-Rad, USA), coupled 
to a refrigeration system. 
The resulting single-strand DNA band patterns were detected by silver staining using 
the PlusOne DNA Silver Staining Kit (Amersham Biosciences, UK). The ovine PRND 
genotypes were established by comparing the SSCP pattern obtaines for each samples 
with the ones characteristic of known PRND polymorphisms as in Pereira et al. (2009). 
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2.2.3. Sequencing 
The sequencing reaction of PCR products from human samples containing the PRND 
gene was directly performed by capillary electrophoresis on an Abi 3130xl sequencer 
(Applied Biosystems, USA), using the same primers as above. 
A bioinformatics analysis were performed by using a basic BLAST (http://blast.ncbi. 
nlm.nih.gov/Blast.cgi) and DNA sequencing results were analyzed using a Sequence 
Scanner (v1.0, Applied Biosystems, USA) for polymorphism identification. 
 
2.3. Semen collection and evaluation 
2.3.1. Semen collection 
Semen collection was conducted at the experimental farm of INIAV in compliance with 
the requirements of the European Union for farm animal’s welfare and the Portuguese 
authority guidelines for animal experimentation. A total of five healthy and fertile rams 
from Churra Galega Mirandesa breed (Ovis aries), belonging to the Portuguese Bank of 
Animal Germplasm (BPGA) located at INIAV, were selected based on their PRND 
genotype (codon 26) – two donors with GG genotype, two with GA genotype, and one 
donor with AA genotype. All rams were kept under identical nutritional conditions and 
held under the same environmental conditions. Fresh semen was collected using an 
artificial vagina following a routine collection period of one time per week/per ram. 
Human spermatozoa were obtained from voluntary male donors and data were 
analyzed and classified into two different groups: fertility status (fertile men, that 
already have progeny without resorting to medically assisted reproduction, vs infertile, 
with no progeny), and fertility treatment (spermogram, fresh sperm analysis; IIU, intra-
uterine sperm injection; and ICSI, intra-cytoplasmic sperm injection). Also, the same 
data were analyzed and classified according to codon 174 genotype of PRND gene, 
3’UTR genotype of the same gene and World Health Organization (WHO) criteria 
(World Health Organization, 2010). The classification according WHO criteria is sub-
divided into asthenozoospermia (<32% progressive motility), oligozoospermia (<15x106 
mL-1), teratozoospermia (<4% normal sperm morphology), oligoasthenozoospermia 
(<15x106 mL-1 and <32% progressive motility), and normozoospermia (none of the 
above). All male donors signed a permission contained in an informed consent 
accordingly to their fertility treatment. 
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2.3.2. Evaluation of fresh semen 
After semen collection, ram samples were placed in a water bath (30oC) and evaluated 
for individual motility (progressive motile spermatozoa), concentration, vitality and 
morphology (Fig. 3). Evaluation of fresh semen was performed in an Olympus BX40 
with an Achromatic 40x/0.65 Ph2 objective and pictures were taken with a Sony 
Exwave HAD DC50AP Color Video Camera with an AMCap software (v8.0). Only good 
quality semen (individual motility > 40%; concentration > 2,5x109 mL-1) was used in 
fresh and thawed assays (Valente et al., 2010). Smear slides were performed for future 
characterization of ovine Doppel expression. 
After collection, human semen samples were incubated for 15-60 min at room 
temperature for liquefaction and evaluated for individual motility (total and 
progressive motility), concentration, vitality and morphology (Kit Diff-Quik, Medion 
Diagnostics International, USA). Smear slides were also performed for future 
characterization of human Doppel expression. 
 
(a) 
(b) 
(b) 
(a) 
(a) 
2. 
1. 
(h) 
(t) 
(m) 
3. 
Fig. 3 – Ram spermatozoa morphology analysis with eosin-nigrosin staining. 
(a) live spermatozoa; (b) dead spermatozoa; (h) head abnormality; (t) tail abnormality; (m) mid piece abnormality. 
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2.3.3. Semen cryopreservation 
After quality assessment, ovine ejaculates were frozen in mini-straws (IMV- 
Technologies®, France) after dilution in cryoprotective medium (15% egg yolk and 6.5% 
glycerol; Table 18, Annex I) to a final concentration of 250-300x106 spz/per straw. The 
mini-straws were refrigerated for 4 h at -4oC, placed in liquid nitrogen vapors for 25 
min by using a Floating Rack System (Minitub®, Germany) and then submersed and 
stored in liquid nitrogen until future fertility assays, as in Pereira et al. (2009). 
For the human samples, 500 µL of semen were frozen in cryotubes after 1:1 dilution in 
the same cryoprotective medium (Table 18, Annex I). The cryotubes were incubated 
for 10 min at room temperature, placed in liquid nitrogen vapor for 15 min and then 
submersed and kept in liquid nitrogen until quality assessment thawing were 
performed. 
 
2.3.4. Evaluation of thawed semen 
For the ram samples, thawing was performed by submerging the straws into a 37oC 
water bath for 30 sec and then semen individual motility and morphology were 
analyzed. The thawed semen was incubated at 38.5oC and 5% CO2 for 1h in modified 
Bracket’s medium containing 20% ovine serum for swim-up (swim-up medium; Table 
19, Annex I) (Marques et al., 2006). Post-swim-up sperm was centrifuged at 1500 rpm 
for 5 min and the supernatant rejected. The individual motility, vigor (0-5) and 
concentration of the remaining pellet were determined and aliquots of this semen 
used for capacitation status evaluation (CTC), for analysis of mitochondrial potential 
(JC-1) and for fertility assays. 
For the human samples, cryotubes were placed at room temperature for 1-2 min for 
thawing process. Semen individual motility and morphology were analyzed. A motile 
sample of frozen-thawed sperm was obtained by centrifugation at 1200 rpm for 15 
min on a density gradient: 1 mL of 50% (v/v) SupraSperm® (diluted in Universal IVF 
medium; Origio, Denmark) over 1 mL of 100% (v/v) SupraSperm®. The supernatant was 
rejected; semen pellet was resuspended in IVF medium and centrifuged for a further 5 
min at 1200 rpm. Semen individual motility, concentration and vitality were analyzed 
in the resulting pellet. All human samples were destroyed after cryo-resistance 
assessment. 
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(B) 
(F) 
(AR) 
1. 2. 
Fig. 4 – Ram spermatozoa capacitation status assessment with chlortetracyclin staining (CTC). 
(B) capacitated with intact acrosome; (F) non-capacitated; (AR) acrosome reacted. 
2.3.5. Capacitation status evaluation (CTC) 
The capacitation status of ovine post-swim-up thawed semen was evaluated using 
chlortetracycline (CTC) staining as described by Pereira et al. (2009), with some 
modifications. Aliquots (5 µL) of this semen were placed in slides and mixed with 5 µL 
CTC staining solution (Table 21, Annex I), 1 µL glutaraldehyde solution (12.5%) and 1 µL 
1,4-Diazabicycol (2.2.2) octane (0.22 M DABCO; Merck, Germany). Slides with 
coverslips were kept protected from the light and 100 cells/ejaculate were analyzed, 
with an Olympus BX51 using an UPlanFI 40x/0.75 NA objective and a BP 470-490 filter, 
within 12-24h. Spermatozoa were classified according to their acrosomal status (Fig. 4) 
as: F pattern (non-capacitated, with fluorescence detected over the whole region of 
the sperm head); B pattern (capacitated with intact acrosome, with fluorescence 
detected in the pre-acrosomal region of sperm head); and AR pattern (reacted 
acrosome, no fluorescence detected over the sperm head or an equatorial bright 
band). Pictures were taken in an Olympus BX60 microscope using an UPlanFL N 
60x/0.9 NA objective and a BP 470-490 filter with Hamamatsu Orca R2 monochromatic 
camera and using the HCI Image Live software (v3.0). 
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2.3.6. Mitochondrial membrane potential (JC-1) 
The inner mitochondrial membrane potential of ram spermatozoa was evaluated using 
JC-1 staining (5,5’,6,6’-tetra-chloro-1,1’,3,3’-tetrathylbenzimidazolycarbocyanine 
iodide; Sigma-Aldrich, USA) according to a technique adapted from Gamboa et al. 
(2010). This cationic dye shows orange-red fluorescence for functional mid piece 
mitochondrial and green fluorescence for low inner mitochondrial membrane 
potential. The post-swim-up semen was diluted to 20x106 mL-1 (Table 22) and 
incubated with JC-1 in dimethyl sulfoxide (2 µM DMSO; Sigma-Aldrich, USA) for 20min 
at 35oC. For a simultaneous vitality evaluation, 50 µL of propidium iodide (PI) were 
added to spermatozoa before incubation. After incubation, 5.5 µL of this semen were 
placed on a slide with coverslip and 100 spermatozoa were analyzed in an Olympus 
BX51 microscope using an UPlanFI 40x/0.75 NA objective and a BP 470-490 filter.  
 
2.4. Fertility assays 
2.4.1. Oocyte collection and In vitro fertilization 
Ovine ovaries were collected from a local abattoir and were carried to the laboratory 
immersed in Dulbecco’s phosphate buffer saline (PBS; Oxoid, Hampshire, England) 
supplemented with 0.15% (w/v) BSA and 0.05 mg mL−1 of kanamycin at 37oC. Follicles 
with 2-6 mm were aspirated with a 5 mL syringe and a 19G needle to obtain immature 
cumulus oocyte complexes (COC). Good quality COCs were selected, washed and then 
incubated in maturation medium (Table 24, Annex I) for 22h at 39oC in a humidified 
atmosphere containing 5% CO2, as in Pereira et al. (2009). 
Mature oocytes were washed to remove excess cumulus cells and then placed in wells 
containing 450 µL of IVF medium (Table 25, Annex I). Each well was inseminated with 
previously capacitated frozen-thawed (FT) semen at a concentration of 1 x 106 mL-1 
and incubated for 18h at 39oC in a humidified atmosphere containing 5% CO2 (Day 0 = 
Day of in vitro fertilization). 
 
2.4.2. Embryo culture 
After 18h of co-incubation, the presumptive zygotes were denuded in synthetic 
oviduct fluid (SOF; Table 23, Annex I) medium enriched with 6 mg mL-1 BSA, 
transferred to culture plates with 25 µL of zygote transfer medium (Table 26, Annex I) 
and incubated at 38.5oC and 5% O2, 5% CO2 and 90% N2 in a humidified atmosphere 
until 2-4-8-cell stage (Day 2). Cleaved embryos were kept in culture medium with 0.6% 
BSA and 10% foetal calf serum (FCS; Sigma-Aldrich, USA; Table 27, Annex I) until the 
blastocyst stage (Day 6-8) without manipulation or medium exchange, as described in 
Pereira et al. (2009). 
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The cleavage rate was recorded on Day 2 as the number of cleavage embryos/per 
number of inseminated oocytes, and the embryo rate was recorded from Days 6 to 8 
as the number of morulae and blastocyst/per number of cleavage embryos. 
 
2.5. Immunolocalization 
The indirect immunofluorescence was used to localize and to characterize the 
expression of PRND gene in ram and human spermatozoa. The flow cytometry was 
performed to assess the specificity of the two anti-Doppel monoclonal antibodies 
produced by mouse immunization in ram spermatozoa. 
 
2.5.1. Indirect immunofluorescence 
Fresh semen from the five rams was diluted in PBS (1:100) and 10 µL of ovine semen 
suspension were used to do smear slides air-dried for 10 min, fixed with methanol air-
dried for 5 min and stored at -20oC. Human smear slides were also prepared using 10 
µL of fresh semen. This technique was adapted from Pimenta et al. (2012b). 
The smear slides were thawed, washed three times with T-PBS and incubated in T-PBS 
(PBS with 0.1% (v/v) Tween-20) supplemented with 5% (w/v) BSA overnight at 4oC to 
block nonspecific sites. Then, slides were washed three times with T-PBS with 5% BSA 
and incubated for 180 min at room temperature (22-24oC) with two (M1 and M2) 
mouse anti-Doppel monoclonal antibodies (1:100 in T-PBS with 5% BSA), from two 
different mouse lineages, or with T-PBS with 5% BSA (used as negative controls). After 
this, smear slides were washed again three times with T-PBS with 5% BSA and 
incubated in the dark for 60 min at room temperature with FITC-conjugated secondary 
antibody (1:3000; Rockland Immunochemicals Inc., Pennsylvania, USA). After 30 min of 
incubation, 5 µL of 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI; Invitrogen, 
USA) were added to the slide for nucleic acid staining, allowing another 30 min of 
incubation. 
Finally, slides were narrowly washed five times with T-PBS and covered with 50 µL of 
glycerol + T-PBS (1:1) and a coverslip. The smear slides were observed at room 
temperature in an Olympus BX60 microscope using a UPlanFL N 60x/0.9 NA objective 
with Hamamatsu Orca R2 monochromatic camera and using the HCI Image Live 
software (v3.0). DAPI fluorescence was detected using a BP 330-385 excitation filter 
and FITC with a BP 470-490 excitation filter. 
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2.5.2. Flow cytometry 
Aliquots of fresh and FT semen were washed and centrifuged twice with PBS 
supplemented with 1% BSA (Sigma-Aldrich, USA) at 1500 rpm for 10 min at room 
temperature. Supernatant was rejected and 100 µL of diluted semen (50 000 mL-1) in 
PBS with 1% BSA were incubated with two different anti-Doppel monoclonal primary 
antibodies (1:100) previously produced (M1 and M2), or with PBS with 1% BSA (used 
as negative control) for 180 min at 4oC. Then, spermatozoa were washed and 
centrifuged twice with PBS at 1500 rpm for 10 min. Supernatant was rejected and 40 
µL of FITC-conjugated secondary antibody (1:100; Rockland Immunochemicals Inc., 
Pennsylvania, USA) were added and incubated for 45 min at 4oC. 
Sperm suspensions were diluted at 1x106 mL-1 and fluorescence was measured on a 
FacsCalibur flow cytometer (Becton-Dickinson Biosciences, USA) equipped with a 488 
nm argon-ion laser. Measurements for at least 20 000 events were collected per 
sample. Data were analyzed using CellQuest software (Becton-Dickinson Biosciences, 
USA). 
This technique was used to distinguish ovine Doppel on fresh and FT spermatozoa 
from rams of the three previously described PRND genotypes, but also to select the 
most specific anti-Doppel monoclonal antibody. 
 
2.6. Statistical analysis 
The results were expressed as least square means ± standard error. The genotype 
frequencies of codon 174 and 3’UTR of human PRND gene were calculated and 
possible deviations from Hardy-Weinberg equilibrium were evaluated using Genepop 
software (v3.4; Laboratoire de Genetique et Environment, Montpellier, France). 
Data representing 3-17 replicates of spermatozoa quality and morphological 
parameters, mitochondrial membrane potential and capacitation status, as well as 4 
replicates for IVF assays, were analyzed using the MIXED procedure of Statistical 
Analysis Systems Institute (SAS Inst., Inc., Cary, NC, USA). The mixed linear model 
included PRND genotypes as fixed effect and replicates as random effect.  Data from 
flow cytometry measurements were analyzed using the same procedure of SAS but 
considering also the semen status (fresh or frozen-thawed) as fixed effect. Human data 
of spermatozoa quality and morphological parameters were equally analyzed including 
PRND genotypes or fertility status or fertility treatments as fixed effect and replicates 
as random effect. When significant effects were identified, values were compared 
using the PDIFF test. Differences were considered significant when P≤0.05. 
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3. RESULTS 
3.1. PRND polymorphisms analysis 
3.1.1. MRF-SSCP 
Three different patterns were identified for exon 2 of ovine PRND gene (Fig. 5) by MRF-
SSCP, which match the patterns previously described by Pereira et al. (2009). This 
identification allowed the selection of 5 rams based on their PRND genotype (2 with 
GG genotype, 2 with GA genotype, and 1 with AA genotype) to be used in the fertility 
assays. 
In human samples, four different patterns (A-D) in exon 2 of human PRND gene (Fig. 6) 
were observed, also by MRF-SSCP. However, in spite of trying several MRF-SSCP 
conditions, it was impossible to obtain really discriminating patterns. Thus, human 
samples were sequenced for polymorphism confirmation. 
 
 
 
  
A B C D 
Fig. 6 – Multiple restriction fragment - single-strand 
conformation polymorphism of human PRND gene. 
Four MRF-SSCP patterns were observed in this study: 
A, B, C and D. 
Fig. 5 – Multiple restriction fragment - single-strand 
conformation polymorphism of ovine PRND gene. 
Three MRF-SSCP patterns were identified in this study: 
GG, GA and AA. 
GG GA AA 
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3.1.2. Sequencing 
Two polymorphisms were detected in the human PRND gene (Fig. 7a – d), within the 
coding sequence of exon 2. A C→T mutation at the second position of codon 174 is 
responsible for an amino acid exchange from threonine to methionine (T174M), which 
matches the mutation described in Peoc’h et al. (2000) and Schröder et al. (2001) (Fig. 
7a – c). Also, a rare polymorphism was observed in 1/28 cases and a G→A non-coding 
change at the third position of codon 174 was also detected (Fig. 7d; Mead et al., 
2000). Another polymorphism outside the coding sequence was also identified (Fig. 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 – Electropherograms of human PRND 3’ UTR polymorphism. 
The nucleotide exchange is indicated by arrows. a) Wild-type sequence (TT); b) mutant genotype (CC); c) 
heterozygous genotype (TC). 
a) b) c) 
Fig. 7 – Electropherograms of human PRND codon 174 polymorphism. 
The nucleotide exchange at the second position is indicated by arrow; the nucleotide exchange at the third 
position is indicated by asterisk. a) Wild-type sequence (CC) - threonine; b) mutant genotype (TT) - methionine; 
c) heterozygous genotype (CT); d) non-coding change at the third position of codon 174. 
a) 
Thr 
b) 
Met 
c) d) 
Thr/Me
t 
* 
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The genotype distribution of both codon 174 and 3’ UTR polymorphisms of PRND gene 
(Table 3 and 4, respectively) was very similar among the male donors. Therefore, there 
were no differences (P>0.05) in genotype distribution between fertile status nor 
among different treatments (sperm analysis, ICSI or IIU) for both codon 174 (Table 3) 
and 3’ UTR polymorphisms (Table 4). However, it was possible to notice an association 
between the two polymorphisms, indicating they are in close association (P=0.018; 
Table 5). This association was also described by Mead et al., (2000). The PRND T allele 
of 3’UTR polymorphism is significantly linked to the PRND C allele of codon 174 
(P≤0.0001; Table 5), whereas the PRND C allele of 3’UTR polymorphism is significantly 
associated with PRND T allele of codon 174 (P=0.001; Table 5). 
 
Table 3 - Genotype distribution at codon 174 of human PRND gene. 
 
 
Codon 174 genotypes Total of 
individuals CC CT TT 
Fertility 
status 
Fertile 1 (33%)  2 (67%)  0 (0%)  3/29 
Infertile 6 (23%)  11 (42%)  9 (35%)  26/29 
Fertility 
treatment 
Spermogram 3 (18%)  10 (59%)  4 (24%)  17/29 
ICSI 1 (20%)  1 (20%)  3 (60%)  5/29 
IIU 3 (43%)  2 (29%)  2 (29%)  7/29 
WHO 
criteria 
Norm 5 (29%)  9 (53%)  3 (18%)  17/29 
AZ 1 (33%)  0 (0%)  2 (67%)  3/29 
OZ 1 (25%)  1 (25%)  2 (50%)  4/29 
TZ 0 (0%)  2 (67%)  1 (33%)  3/29 
OAZ 0 (0%)  1 (50%)  1 (50%)  2/29 
Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, homozygous mutant genotype. 
Fertile, male donors that already have progeny without resorting to medically assisted reproduction; Infertile, male 
donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: IIU, intra-
uterine sperm injection. WHO criteria: AZ, asthenozoospermia; OZ, oligozoospermia; TZ, teratozoospermia; OAZ, 
oligoasthenozoospermia; Norm, normozoospermia. 
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Table 4 - Genotype distribution of 3'UTR polymorphism of human PRND gene. 
 
 
3' UTR polymorphism genotypes Total of 
individuals TT TC CC 
Fertility 
status 
Fertile 1 (33%)  2 (67%)  0 (0%)  3/29 
Infertile 6 (23%)  10 (38%)  10 (38%)  26/29 
Fertility 
treatment 
Spermogram 3 (18%)  9 (53%)  5 (29%)  17/29 
ICSI 1 (20%)  1 (20%)  3 (60%)  5/29 
IIU 3 (43%)  2 (29%)  2 (29%)  7/29 
WHO 
criteria 
Norm 5 (29%)  9 (53%)  3 (18%)  17/29 
AZ 1 (33%)  0 (0%)  2 (67%)  3/29 
OZ 1 (25%)  1 (25%)  2 (50%)  4/29 
TZ 0 (0%)  2 (67%)  1 (33%)  3/29 
OAZ 0 (0%)  0 (0%)  2 (100%)  2/29 
3’ UTR polymorphism genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, homozygous mutant 
genotype. Fertile, male donors that already have progeny without resorting to medically assisted reproduction; 
Infertile, male donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: 
IIU, intra-uterine sperm injection. WHO criteria: AZ, asthenozoospermia; OZ, oligozoospermia; TZ, 
teratozoospermia; OAZ, oligoasthenozoospermia; Norm, normozoospermia. 
 
Table 5 – Genotype frequencies relative to single nucleotide polymorphisms detected in codon 174 and 3’ UTR 
polymorphisms of the human PRND gene, in 29 Portuguese male donors. 
  3’ UTR genotypes 
  TT TC CC 
Codon 
174 
genotypes 
CC 1.000 a 0.000 a 0.000 a 
CT 0.000 b 0.923 b 0.077 b 
TT 0.000 c 0.000 c 1.000 c 
3’ UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, homozygous mutant genotype. 
Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, homozygous mutant genotype. 
Values within columns with different letters differ statistically (P<0.001). 
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3.2. Fertility tests 
The volume, individual motility (MI) and vitality of ovine fresh semen presented no 
differences (P>0.05) among animals with different PRND genotypes (Table 6). 
However, animals with PRND AA genotype showed lower sperm concentration in fresh 
ejaculates when compared to animals with PRND GA (P<0.006) and GG (P<0.008) 
genotypes (Table 6). 
 
Table 6 – Quality parameters evaluation of fresh semen from Churra Galega Mirandesa rams classified according 
to codon 26 genotype of PRND gene (least squares means ± standard error). 
PRND genotype n 
Volume 
(mL) 
Concent 
(109 mL-1) 
MI 
(%) 
Vitality 
(%) 
AA 7 0.4 ± 0.10 2.4 ± 0.50 a 63.3 ± 2.59 75.3 ± 6.49 
GA 17 0.7 ± 0.06 4.3 ± 0.30 b 63.6 ± 1.73 68.5 ± 3.88 
GG 11 0.5 ± 0.08 4.3 ± 0.36 b 61.0 ± 1.91 68.5 ± 4.81 
AA, rare homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of samples; 
Concent, spermatozoa concentration; MI, individual spermatozoa motility; Values within columns with different 
letters differ statistically (P≤0.008) 
 
The thawed and post-swim-up MI, vigor, concentration, vitality and inner 
mitochondrial membrane potential from post-swim-up frozen-thawed (FT) ram semen 
(Table 7), as well as the capacitation status (Table 8), presented no differences 
(P>0.05) among rams with distinct PRND genotypes. 
 
Table 7 – Quality parameters evaluation of frozen-thawed  semen from Churra Galega Mirandesa rams classified 
according to codon 26 genotype of PRND gene (least squares means ± standard error). 
P
R
N
D
 
ge
n
o
ty
p
e
 
n 
Thawed   Post-swim-up 
MI (%) MI (%) 
Vigor 
(0-5) 
Concent 
(x106 mL-1) 
Vitality (%) n ∆ψmit (%) 
AA 7 44.0 ± 3.22 66.9 ± 6.24 4.2 ± 0.19 66.9 ± 57.55 38.2 ± 5.38 4 54.3 ± 10.41 
GA 21 41.5 ± 1.92 53.3 ± 3.94  4.2 ± 0.13 126.2 ± 34.89 51.2 ± 3.47 13 50.4 ± 5.66 
GG 19 40.2 ± 2.01 53.4 ± 4.02 4.3 ± 0.13 197.8 ± 35.69 43.8 ± 4.02 13 66.9 ± 5.63 
AA, rare homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of samples; MI, 
individual spermatozoa motility; Concent, spermatozoa concentration; ∆ψmit, inner mitochondrial membrane 
potential. 
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Table 8 – Capacitation status evaluation of frozen-thawed semen from Churra Galega Mirandesa rams classified 
according to codon 26 genotype of PRND gene (least squares means ± standard error). 
PRND 
genotype 
n 
Capacitation status (%) 
F  B  AR  
AA 7 26.2 ± 4.32 60.5 ± 7.43 17.2 ± 6.85 
GA 21 18.6 ± 2.90 57.4 ± 6.62 22.8 ± 5.86 
GG 19 19.4 ± 2.98 57.5 ± 6.66 22.5 ± 5.90 
AA, rare homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of samples; F, non-
capacitated; B, capacitated with intact acrosome; AR, reacted acrosome. 
 
Semen morphological evaluation showed that rams with PRND GG genotype had more 
(P=0.04) morphological abnormalities in fresh samples when compared to rams with 
GA PRND genotype (Table 9). Also, spermatozoa mid piece abnormalities were higher 
in fresh semen from animals with PRND GG genotype when compared to samples from 
rams carrying PRND AA (P=0.02) and GA (P=0.001) genotype (Table 9). In FT samples, 
there were no significant differences (P>0.05) between animals with distinct PRND 
genotypes. 
 
Table 9 – Morphological evaluation of fresh (F) and frozen-thawed (FT) semen from Churra Galega Mirandesa 
rams classified according to codon 26 genotype of PRND gene (least squares means ± standard error). 
PRND 
genotype 
n 
Sperm morphology (%) 
Normal Head Mid piece Tail 
Fresh 
AA 6 84.7 ± 3.09 ab 4.8 ± 2.34 2.7 ± 1.16 a 6.2 ± 2.30 
GA 17 88.7 ± 2.06 a 6.7 ± 1.53 3.1 ± 0.69 a 1.9 ± 1.53 
GG 11 83.0 ± 2.18 b 7.6 ± 1.76 6.7 ± 0.86 b 3.5 ± 1.62 
FT 
AA 6 79.2 ± 4.68 13.2 ± 3.79 2.4 ± 1.78 5.2 ± 1.91 
GA 13 77.1 ± 3.09 16.4 ± 2.48 2.5 ± 1.13 4.4 ± 1.26 
GG 11 73.8 ± 3.24 16.2 ± 2.62 6.0 ± 1.22 4.0 ± 1.32 
AA, rare homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of samples; 
Normal, normal spermatozoa morphology; Head, spermatozoa head defect; Mid piece, spermatozoa mid piece 
defect; Tail, spermatozoa tail defect; Fresh, fresh semen; FT, frozen-thawed semen; Values within columns with 
different letters differ statistically (P≤0.02) 
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No differences were observed in cleavage rate (P>0.05) after fertilization with FT 
semen from rams with distinct PRND genotypes (Table 10; Fig. 9). However, rams 
carrying PRND AA genotype showed higher (P<0.004) embryo rate at day 6/7 when 
compared to rams with PRND GG or GA genotype (Table 10). 
 
Table 10 – IVF parameters evaluation of fertilization with frozen-thawed semen from Churra Galega Mirandesa 
rams classified according to codon 26 genotype of PRND gene (least squares means ± standard error). 
PRND 
genotype 
n 
Cleavage rate 
(%) 
D6/7 embryo rate 
(%) 
AA 372 40.4 ± 3.69 26.6 ± 3.32 a 
GA 909 37.0 ± 2.99 14.7 ± 2.39 b 
GG 861 40.2 ± 3.00 15.2 ± 2.31 b 
AA, rare homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of inseminated 
oocytes; Values within columns with different letters differ statistically (P≤0.004) 
 
 
 
 
 
 
  
Fig. 10 – Ovine hatching blastocyst (day 6/7) 
128x 
Fig. 9 – Ovine cleaved embryo (day 2) 
100x 
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In what concerns human results, quality evaluation of fresh sperm only highlighted 
that fertile male donors had less (P=0.03) sperm volume, comparing to infertile ones 
(Table 11). Also, fresh sperm concentration tend to be superior (P=0.08) in fertile male 
donors than in infertile ones (Table 11). Moreover, total MI, progressive MI and vitality 
presented no differences (P>0.05) among donors classified according to their distinct 
sperm analysis (fertility status, fertility treatment) or PRND genotypes (codon 174 and 
3’UTR polymorphisms; Table 11). 
Frozen-thawed sperm evaluation presented no differences (P>0.05) among different 
sperm analysis (Table 12). However, FT sperm vitality tends to be superior (P=0.09) in 
samples from male donors carrying CC genotype of codon 174 polymorphism (Table 
12). 
 
Table 11 – Quality parameters evaluations of fresh semen from Portuguese human male donors classified 
according to their fertility status, fertility treatment, codon 174 or 3’UTR genotypes of PRND (least squares means 
± standard error). 
 
n 
Volume 
(mL) 
Concent 
(106 mL-1) 
Total MI 
(%) 
Progressive 
MI (%) 
Vitality 
(%) 
Fe
rt
ili
ty
 
st
at
u
s Fertile 3 1.3 ± 0.60 a 93.5 ± 24.09 48.3 ± 6.61 40.5 ± 6.61 75.7 ± 6.71 
Infertile 26 2.8 ± 0.12 b 46.5 ± 8.18 47.3 ± 2.25 38.4 ± 2.33 73.1 ± 2.28 
Fe
rt
ili
ty
 
tr
e
at
m
e
n
t Spermogram 17 2.6 ± 0.31 56.2 ± 10.85 46.4 ± 2.81 37.1 ± 2.90 74.8 ± 2.85 
ICSI 5 1.8 ± 0.51 43.6 ± 20.00 53.2 ± 5.10 43.3 ± 5.12 70.8 ± 5.25 
IIU 7 2.9 ± 0.44 45.3 ± 16.90 45.3 ± 4.32 38.6 ± 4.36 71.9 ± 4.44 
C
o
d
o
n
 1
7
4
 
ge
n
o
ty
p
e
s CC 7 2.0 ± 0.43 46.3 ± 16.73 50.7 ± 4.31 37.8 ± 4.28 81.0 ± 4.14 
CT 13 2.9 ± 0.33 60.7 ± 12.35 47.7 ± 3.16 40.6 ± 3.20 71.8 ± 3.03 
TT 9 2.6 ± 0.41 41.7 ± 14.03 44.4 ± 3.80 36.1 ± 3.91 69.8 ± 3.65 
3
’U
TR
 
ge
n
o
ty
p
es
 TT 7 2.0 ± 0.43 46.2 ± 16.83 50.7 ± 4.25 37.8 ± 4.23 81.0 ± 4.14 
TC 12 2.9 ± 0.34 59.7 ± 12.88 48.8 ± 3.24 41.5 ± 3.31 71.7 ± 3.16 
CC 10 2.6 ± 0.40 44.9 ± 14.17 43.5 ± 3.55 35.3 ± 3.78 70.1 ± 3.46 
Fertile, male donors that already have progeny without resorting to medically assisted reproduction; Infertile, male 
donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: IIU, intra-
uterine sperm injection; Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, 
homozygous mutant genotype; 3’ UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, 
homozygous mutant genotype; n, number of samples from male donors; Concent, spermatozoa concentration; 
Total MI, spermatozoa individual motility, including progressive motility; Progressive MI, spermatozoa with straight 
line motility; Values within columns with different letters differ statistically (P<0.03) 
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Table 12 – Quality parameters evaluations of frozen-thawed semen from Portuguese human male donors 
classified according to their fertility status, fertility treatment, codon 174 or 3’UTR genotypes of PRND (least 
squares means ± standard error). 
 n 
Thawed After centrifugation with density gradient 
MI 
(%) 
MI (%) 
Concent 
(106 mL-1) 
Vitality (%) 
Fe
rt
ili
ty
 
st
at
u
s Fertile 3 27.3 ± 7.08 46.5 ± 14.56 6.3 ± 5.04 34.5 ± 13.07 
Infertile 26 15.6 ± 2.76 36.1 ± 6.24 7.0 ± 2.09 29.4 ± 5.40 
Fe
rt
ili
ty
 
tr
ea
tm
en
t Spermogram 17 19.6 ± 2.94 36.8 ± 6.59 7.4 ± 2.31 30.5 ± 5.77 
ICSI 5 9.3 ± 5.88 32.6 ± 11.08 5.3 ± 4.04 21.2 ± 10.38 
IIU 7 14.3 ± 4.45 41.9 ± 8.83 6.4 ± 3.17 32.8 ± 8.06 
C
o
d
o
n
 1
7
4
 
ge
n
o
ty
p
e
 CC 7 17.5 ± 4.91 45.6 ± 8.66 6.4 ± 3.22 42.0 ± 7.63 
CT 13 19.3 ± 3.40 36.8 ± 6.53 7.9 ± 2.42 30.2 ± 5.62 
TT 9 12.5 ± 4.40 30.4 ± 8.32 5.3 ± 3.09 18.5 ± 7.24 
3
’U
TR
 
ge
n
o
ty
p
e
 TT 7 17.5 ± 4.78 45.7 ± 8.46 6.3 ± 3.18 41.9 ± 7.79 
TC 12 20.4 ± 3.41 38.7 ± 6.45 5.9 ± 2.41 29.1 ± 5.87 
CC 10 11.4 ± 4.01 26.8 ± 7.96 9.3 ± 2.97 20.8 ± 7.25 
Fertile, male donors that already have progeny without resorting to medically assisted reproduction; Infertile, male 
donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: IIU, intra-
uterine sperm injection; Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, 
homozygous mutant genotype; 3’ UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, 
homozygous mutant genotype; n, number of samples from male donors; Concent, spermatozoa concentration; MI, 
individual spermatozoa motility. 
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No differences (P>0.05) were found in fresh (Table 13) or FT (Table 14) human sperm 
morphological analysis. Still, FT samples from fertile male donors tend to possess more 
(P=0.07) sperm mid piece abnormalities (Table 14). 
 
Table 13 – Morphological evaluation of fresh semen from human male donors classified according to their 
fertility status, fertility treatment, codon 174 or 3’UTR genotypes of PRND (least squares means ± standard error) 
n 
Fresh sperm morphology (%) 
Normal Head Mid piece Tail 
Fe
rt
ili
ty
 
st
at
u
s Fertile 3 12.9 ± 5.02 64.1 ± 13.66 11.8 ± 6.12 10.4 ± 9.17 
Infertile 26 8.1 ± 2.21 74.7 ± 6.14 8.1 ± 2.76 9.6 ± 3.97 
Fe
rt
ili
ty
 
tr
ea
tm
en
t Spermogram 17 7.9 ± 1.95 76.0 ± 6.47 7.0 ± 2.78 9.8 ± 4.40 
ICSI 5 11.2 ± 2.33 74.7 ± 8.61 7.9 ± 3.68 6.4 ± 6.43 
IIU 7 8.6 ± 2.19 65.2 ± 7.76 13.0 ± 3.33 12.0 ± 5.63 
C
o
d
o
n
 1
7
4
 
ge
n
o
ty
p
e
 CC 7 9.3 ± 2.13 72.9 ± 8.00 11.4 ± 3.47 5.8 ± 5.73 
CT 13 7.8 ± 1.97 75.7 ± 6.86 6.9 ± 2.98 10.2 ± 4.66 
TT 9 9.1 ± 2.16 68.2 ± 8.07 8.9 ± 3.50 13.0 ± 5.65 
3
’U
TR
 
ge
n
o
ty
p
e
 TT 7 9.3 ± 2.13 72.9 ± 8.08 11.4 ± 3.51 5.8 ± 5.74 
TC 12 8.0 ± 1.99 73.8 ± 7.07 8.1 ± 3.12 10.6 ± 4.84 
CC 10 8.8 ± 2.18 71.4 ± 8.23 6.7 ± 3.60 12.2 ± 5.66 
Fertile, male donors that already have progeny without resorting to medically assisted reproduction; Infertile, male 
donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: IIU, intra-
uterine sperm injection; Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, 
homozygous mutant genotype; 3’ UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, 
homozygous mutant genotype; n, number of samples from male donors; Normal, normal spermatozoa morphology; 
Head, spermatozoa head defect; Mid piece, spermatozoa mid piece defect; Tail, spermatozoa tail defect. 
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Table 14 – Morphological evaluation of frozen-thawed semen from human male donors classified according to 
their fertility status, fertility treatment, codon 174 or 3’UTR genotypes of PRND (least squares means ± standard 
error) 
n 
Frozen-thawed sperm morphology (%) 
Normal Head Mid piece Tail 
Fe
rt
ili
ty
 
st
at
u
s Fertile 3 10.3 ± 3.63 63.7 ± 8.74 17.3 ± 3.00 8.7 ± 5.53 
Infertile 26 7.8 ± 1.28 69.4 ± 3.17 11.3 ± 1.06 11.0 ± 1.95 
Fe
rt
ili
ty
 
tr
ea
tm
en
t Spermogram 17 8.8 ± 1.54 66.8 ± 3.77 12.6 ± 1.37 10.8 ± 2.44 
ICSI 5 10.8 ± 3.08 67.3 ± 7.54 13.3 ± 2.75 8.8 ± 4.88 
IIU 7 5.1 ± 2.33 73.3 ± 5.70 9.7 ± 2.08 11.9 ± 3.69 
C
o
d
o
n
 1
7
4
 
ge
n
o
ty
p
e
 CC 7 10.5 ± 2.49 67.5 ± 6.28 12.2 ± 2.27 9.8 ± 3.97 
CT 13 8.8 ± 1.69 68.9 ± 4.28 10.9 ± 1.54 10.0 ± 2.70 
TT 9 5.1 ± 2.16 69.0 ± 5.48 13.4 ± 1.97 12.6 ± 3.44 
3
’U
TR
 
ge
n
o
ty
p
e
 TT 7 10.5 ± 2.45 67.5 ± 6.25 12.2 ± 2.31 9.8 ± 3.89 
TC 12 9.3 ± 1.74 70.2 ± 4.43 11.7 ± 1.64 8.9 ± 2.75 
CC 10 5.0 ± 2.00 67.2 ± 5.14 12.1 ± 1.89 13.8 ± 3.18 
Fertile, male donors that already have progeny without resorting to medically assisted reproduction; Infertile, male 
donors with no progeny; Spermogram, fresh sperm analysis; ICSI, intra-cytoplasmic sperm injection: IIU, intra-
uterine sperm injection; Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, 
homozygous mutant genotype; 3’ UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, 
homozygous mutant genotype; n, number of samples from male donors; Normal, normal spermatozoa morphology; 
Head, spermatozoa head defect; Mid piece, spermatozoa mid piece defect; Tail, spermatozoa tail defect. 
 
The association between human sperm traits and the linkage of codon 174 and 3’UTR 
polymorphisms were analyzed and no differences (P>0.05) were established (data not 
shown). Nevertheless, the absence of linkage between the two polymorphisms 
exhibited higher (P<0.001; Table 15) FT viable sperm concentration after centrifugation 
with density gradient, when compared to the existence of the same linkage (Table 15). 
Table 15 – Relationship between human FT sperm concentration and the linkage of codon 174 and 3’UTR 
polymorphisms or human PRND gene (least squares means ± standard error) 
Linkage between polymorphisms 
n 
Concent 
(106 mL-1) Codon 174 genotypes 3’UTR genotypes 
CC TT 7 4.9 ± 2.31 a 
CT TC 12 6.1 ± 2.02 a 
TT CC 9 6.8 ± 2.39 a 
CT TT 1 31.6 ± 4.89 b 
Codon 174 genotypes: CC, wild-type genotype; CT, heterozygous genotype; TT, homozygous mutant genotype; 3’ 
UTR genotypes: TT, wild-type genotype; TC, heterozygous genotype; CC, homozygous mutant genotype; Concent, 
spermatozoa concentration; Values within columns with different letters differ statistically (P<0.001) 
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3.3. Indirect immunofluorescence 
Ovine Doppel protein was detected in ejaculated ram spermatozoa. Identical patterns 
were observed in ovine Doppel immunofluorescence localization using M1 or M2 
antibodies. Positive fluorescence in sperm head apical region, mid piece and tail were 
observed (Fig. 11a and b).  However, occasionally a faint immunofluorescence staining 
was also present on the flagella of ram spermatozoa in the negative control (Fig. 11c). 
Also, sometimes the fluorescence in sperm head apical region showed a faded 
positivity (Fig. 11b), so it was difficult to detect differences among samples from rams 
classified according to their PRND genotypes. 
 
 
 
 
 
 
 
 
 
 
 
Identical patterns between M1 and M2 antibodies were observed in human Doppel 
immunofluorescence localization. Shifting positive fluorescence in sperm head and mid 
piece was detected in human spermatozoa (Fig. 12a and c), and a faded positivity in 
human sperm flagella was also observed (Fig. 12c). Nonetheless, this fluorescence 
patterns were also observed in the negative controls (Fig. 12b and d). Due to the 
similar fluorescence signal among positive and negative human samples, it was difficult 
to correlate the fluorescence patterns with human Doppel expression. 
  
(b) 
Fig. 11 – Immunofluorescence images of Doppel protein location in ram ejaculated spermatozoa. 
(a) and (b) M1 in spermatozoa from rams with different PRND genotype (c) T-PBS, used as negative 
control. FITC-conjugated secondary antibody (green), DAPI (nucleus/nucleus), scale bar: 10 µm. 
(c) (a) 
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(a) 
(c) 
(b) 
(d) 
Fig. 12 - Immunofluorescence images of Doppel protein location in human ejaculated spermatozoa. 
(a) and (c) T-PBS, used as negative control; (b) and (d) M1 in spermatozoa from human male donors with 
different PRND polymorphisms. FITC-conjugated secondary antibody (green), DAPI (nucleus/blue), scale bar: 
10 µm. 
Negative controle (TBS) 
Monoclonal antibody M1 
(Sperm + M1 + FITC) 
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3.4. Flow cytometry 
Ovine Doppel protein was detected in ram spermatozoa by flow cytometry through an 
increase in the fluorescent signal using both produced antibodies M1 and M2 (Fig. 13 
and 14). As control, we used the fluorescent signal obtained with ram spermatozoa + 
FITC-conjugated secondary antibody. As described in Table 16, the M1 monoclonal 
antibody exhibited superior fluorescent signal when compared to M2. 
No differences (P>0.05) in ovine Doppel detection were identified among sperm 
samples from animals with different PRND genotypes (Table 16). However, these 
results also showed the detection of a superior Doppel relative fluorescence when 
analyzing ram fresh semen (Fig. 14a), compared to FT semen samples (Fig. 14b), using 
both M1 and M2 (P<0.03 and P<0.05, respectively; Table 16). 
 
Table 16 – Fluorescent signals obtained with anti-Doppel monoclonal antibodies M1 and M2, for ovine fresh and 
FT semen, and for semen of Churra Galega Mirandesa rams classified according to codon 26 genotype of PRND 
gene (least squares means ± standard error). 
Anti-Doppel 
monoclonal antibody 
n 
PRND genotypes  Semen 
AA GA GG  Fresh FT 
M1 14 1.63 ± 0.30 1.40 ± 0.18 1.59 ± 0.20  1.87 ± 0.17 a 1.21 ± 0.19 b 
M2 14 1.44 ± 0.43 1.18 ± 0.29 1.60 ± 0.29  1.70 ± 0.22 a 1.12 ± 0.24 b 
M1, anti-Doppel monoclonal antibody M1-2C10; M2, anti-Doppel monoclonal antibody M2-15.5; AA, rare 
homozygous mutant; GA, heterozygous mutant; GG, homozygous wild-type; n, number of samples; Fresh, fresh 
semen; FT, frozen-thawed semen; Values within rows with different letters differ statistically (P≤0.05) 
 
  
Fig. 13 – Flow cytometry of correctly oriented fresh sperm (region R1) from ram with 
PRND AA genotype (forward scatter versus side scatter). 
53 
 
 
 
  
Sperm + FITC 
Sperm + M2 + FITC 
Sperm 
Sperm + M1 + FITC 
(a) 
Fig. 14 – Flow cytometry of fresh and frozen-thawed sperm from ram with PRND AA genotype. 
(a) R1 histogram output for fresh spermatozoa; (b) R1 output for FT spermatozoa. Fluorescent signals were 
detected for spermatozoa (Sperm), spermatozoa plus FITC-conjugated secondary antibody (Sperm + FITC), 
spermatozoa plus M1 antibody (Sperm + M1 + FITC) and spermatozoa plus M2 antibody (Sperm + M2 + FITC). 
Sperm + M2 + FITC 
Sperm + FITC 
Sperm 
Sperm + M1 + FITC 
(b) 
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4. DISCUSSION 
The prion genetic complex comprises one prion gene and three prion-like genes which 
show similar genetic organization, although their biological functions remain largely 
unclear (Premzl and Gamulin, 2007; Pimenta et al., 2011). Since the surprising 
discovery of PRND, located downstream PRNP (Moore et al., 1999), several authors 
have suggested a major role for Doppel in the reproductive field. Doppel protein can 
be found in Sertoli and germ cells in several different species, including ovine (Espenes 
et al., 2005) and human (Peoc’h et al., 2002), in Leydig cells (Kocer et al., 2007) and 
also in epididymis epithelial cells (Serres et al., 2006). All these results, combined with 
the sterility presented by PRND0/0 mice (Behrens et al., 2002), point to an important 
physiological function on male fertility (Peoc’h et al., 2002; Rondena et al., 2005; 
Serres et al., 2006; Kocer et al., 2007; Pereira et al., 2009; Pimenta et al., 2012a). 
Likewise, our research group suggested a possible association between PRND gene 
polymorphisms and ram sperm traits, freezability and consequent fertility (Baptista et 
al., 2008; Pereira et al., 2009). Therefore, the first objective of this work was to 
compare the quality and freezability of sperm obtained from rams with different 
previously identified polymorphisms in codon 26 of PRND gene. As abnormal PRND 
gene expression may be involved in human male sterility (Peoc’h et al., 2002), we also 
investigated if the presence of PRND polymorphisms would affect the quality, 
freezability and Doppel expression of human spermatozoa.  
According to Mesquita et al. (2010), in the ovine Portuguese breeds, the only 
polymorphism identified in the PRND gene coding region is the synonymous 78G>A 
substitution in codon 26, coding for Alanine.  Although Churra Galega Mirandesa breed 
has a significantly higher prevalence of heterozygotes GA (25%), when compared to 
the total population, thus being the eligible breed for the present study, the A allele is 
globally presented at low frequencies. Due to the rareness of animals with PRND AA 
genotype (Pereira et al., 2009; Mesquita et al., 2010), only one ram from Churra 
Galega Mirandesa breed was found to have this PRND genotype. 
Previously, Baptista et al. (2008) identified an improved sperm fresh vitality and a 
decrease of FT sperm head anomalies in samples from rams carrying the PRND GA 
genotype compared to those with the GG one.  In the present work, animals classified 
with GG genotype presented also more (P=0.04) morphological abnormalities 
(including spermatozoa mid piece defects; P=0.01) than GA or AA rams, but in fresh 
sperm. However, no differences were observed in sperm vitality (Table 6 and 7) and 
post-thawed morphology among animals with distinct PRND genotypes (Table 9). In 
what concerns post-swim-up spermatozoa quality parameters, no differences were 
identified among animals with distinct PRND genotypes either (Table 7). 
Notwithstanding, FT semen from rams carrying the AA genotype significantly (P≤0.04) 
increased embryo rates when compared with the other two genotypes (Table 10). As 
in Pereira et al. (2009), no differences were identified in embryo production rates 
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obtained with sperm from GG and GA rams. Nevertheless, in the latter study these 
authors did not test semen from AA rams. The spermatozoa fertilizing capacity is the 
best indicator of post-thawed sperm quality (Morris et al., 2001; Valente et al., 2010) 
which is undoubtedly augmented in our ram presenting the rare PRND AA genotype. 
Although the identified polymorphism in the ovine PRND gene is a synonymous one 
(G>A), recent studies have indicated that both synonymous and non-synonymous SNPs 
can influence mRNA stability, processing and maturation, thereby affecting its allelic 
expression (Komar, 2007). Moreover, synonymous codon substitutions (namely 
changes from frequent to infrequent codons) may lead to different kinetics of mRNA 
translation (protein), and thus affect the co-translational folding pathway, yielding a 
protein with a different final structure and function (Komar, 2007). Besides presenting 
the higher prevalence of the rare allele A, the Churra Galega Mirandesa breed has the 
lowest ARR/ARR genotype frequency of our local breeds (Mesquita et al., 2010). Thus 
the European Union selection program to eradicate scrapie, based only on PRNP  
genotypes (Ehling et al., 2006; Gama et al., 2006), can have unintended consequences 
on this particular breed, and possible repercussions on reproduction traits and genetic 
diversity of sheep European breeds. Moreover, previous work from our group (Baptista 
et al., 2008; Pereira et al., 2009; Mesquita et al., 2010) focused on this synonymous 
polymorphism located in codon 26 of the ovine PRND gene, helped to reinforce the 
relevance of the Dpl N-terminal region through the established association with the 
susceptibility to scrapie disease and ram reproductive traits. However, it remains 
unclear whether this polymorphism could modify structural and/or functional aspects 
of Doppel, affecting spermatozoa fertilizing capacity as shown in the present study. 
In human, our results suggest no relationship between the distribution of PRND codon 
174 genotypes and male classified according to their fertility status (fertile men, that 
already have progeny without resorting to medically assisted reproduction, vs infertile, 
with no progeny) or to fertility treatment at the Center of Medical Reproduction of 
British Hospital Lisbon XXI (spermogram, IIU and ICSI) or to WHO classification (P>0.05; 
Table 3), as also described by Peoc’h et al. (2002). This polymorphism within the 
coding sequence of exon 2 (codon 174 of PRND gene) is quite frequent among men 
and it lies at three residues from C-terminal hydrophobic sequence, so according to 
several authors, it would be unlikely to affect Doppel protein structure and/or 
function, impairing spermatogenesis and/or sperm motility (Mead et al., 2000; 
Schröder et al., 2001; Peoc’h et al., 2002). However herein male donors carrying the CC 
genotype (wild-type) tend to have a higher (P=0.09; Table 12) FT sperm vitality when 
compared to the other two (CC=42.0 ± 7.63%, CT=30.2 ± 5.62% and TT=18.5 ± 7.24%; 
Table 12). On the other hand, the 3’UTR polymorphism lies 38 bp 3’ to the codon 174 
and this two polymorphisms are in linkage (Table 5; Mead et al., 2000). Still, the 
relationship between the 3’UTR polymorphisms and male reproduction remains 
unclear (Table 4). Noteworthy, in the analyzed male donors, the PRND T allele of 3’UTR 
polymorphism is linked (P<0.0001) to the PRND C allele of codon 174, whereas the 
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PRND C allele of 3’UTR polymorphism is significantly associated with PRND T allele of 
codon 174 (P=0.001) and differences were identified among their quality parameters 
evaluations of FT semen (Table 5). Interestingly, after analyzing these male donors 
according to their linkage between codon 174 and 3’UTR polymorphisms, a five times 
higher (P<0.001) number of viable spermatozoa after thawing and centrifugation in 
density gradients were identified in male donors with no linkage between this 
polymorphisms than in those carrying  the linkage (Table 15). As viable spermatozoa 
are of primordial importance to successfully fertilize the oocyte, these results may 
have implications on the clinical approach to the infertile men and ART outcomes. 
However, a total of 29 male donors is not a representative group and further 
investigation is needed. Moreover, a silent polymorphism was also observed in codon 
174 at the third position in only 1/29 individual (Fig. 7d), which also carried the wild-
type polymorphism for the regular codon 174. This rare polymorphism was already 
described by Mead et al. (2000), but up to now no correlation with male fertility has 
been pointed out.  Taking altogether, our results indicate that male donors carrying 
distinct PRND genotypes may present differences in the quality and freezability of 
ejaculates, which could represent an interesting path for future research. 
Typically defined as a failure to conceive after a year of regular unprotected 
intercourse, infertility affects 8% to 16% of reproductive age couples. This condition 
can be caused by disruptions at various steps of the reproductive process (Medical 
Advisory Secretariat, 2006). According to Agarwal et al. (2014), spermatozoa 
morphology is probably the most relevant parameter of traditional semen evaluation, 
providing information of the fertilization potential, having the best indication value of 
poor semen quality in the laboratory assessment of infertile men. Besides that, our 
results suggest that fertile male donors have less sperm volume (P=0.03; Table 11), 
and a tendency to present higher sperm concentration (P=0.08; Table 11); our results 
from FT samples from fertile male donors also highlight the tendency to present more 
spermatozoa mid piece abnormalities (P=0.07; Table 14). Although analyzing sperm 
data from a small population, the differences between fertile and infertile males or 
males classified according their applied treatments showed a pale positivity.  These 
results are in accordance with the reported growing prevalence of men infertility. 
As referred, Doppel is permanently expressed in Sertoli cells, but its expression in the 
germ cells can vary accordingly to species (Moore et al., 1999; Silverman et al., 2000; 
Tranulis et al., 2001; Peoc’h et al., 2002; Rondena et al., 2005; Serres et al., 2006; 
Kocer et al., 2007; Pimenta et al., 2012a). In ovine, Espenes et al. (2005) detected 
Doppel in the seminiferous epithelium in the final stages of spermatogenesis, but not 
in the ejaculated spermatozoa. On the other hand, bovine and human Doppel was 
found to be expressed in the ejaculated spermatozoa (Rondena et al., 2005; Serres et 
al., 2006). Moreover, in human Peoc’h et al. (2002) detected this protein on the 
flagella of mature ejaculated spermatozoa and suggested its involvement in the 
motility and in active protection of the spermatozoa. In bovine, an intense staining 
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extending from the neck to the middle piece was detected in ejaculated spermatozoa 
(Rondena et al., 2005). In our study, using indirect immunofluorescence technique, 
ovine Doppel could be detected in ejaculated spermatozoa. However, the staining 
pattern of ovine Doppel is not easy to achieve in spermatozoa, as referred also by 
Espenes et al. (2005). Positive fluorescence in ram sperm head apical region, mid piece 
and tail could be observed, although the sperm head fluorescence was not always 
present. Also, as in Pimenta et al. (2012b), a nonspecific staining from the FITC-
conjugated secondary antibody in sperm mid piece and tail was sometimes identified 
in ovine spermatozoa, although the brightness intensity was superior in the presence 
of the produced monoclonal anti-Doppel antibodies, M1 or M2. Nevertheless it was 
not possible to quantify differences among samples from rams classified according to 
their PRND genotypes. This might suggest an expression level in ovine  smaller than the 
detection limit of this method (as previously referred by Espenes et al. (2005)) or a 
different biological behavior of ovine Doppel protein related to different location of 
both soluble and insoluble forms in the male germ cells, demanding further studies. In 
human spermatozoa, the positive staining in sperm head, mid piece and tail was also 
detected in the negative controls. Accordingly to WHO (World Health Organization, 
2010), male donors with more than 4% of spermatozoa with normal morphology are 
considered fertile, a fact that point out the elevated prevalence of abnormal human 
spermatozoa. Thereby, the low presence of morphologic normal sperm might dilute 
and/or mask the real human Doppel localization. Thus, our produced antibodies could 
not specifically detect human Doppel expression in ejaculated spermatozoa.  
In ovine testis, Doppel protein appears to carry two N-glycans, but apparently lacks O-
glycans (Espenes et al., 2005). After being synthesized in the endoplasmic reticulum, 
the Doppel polypeptide is processed at its C- and N- terminus and is then exposed to 
the cell membrane (Uelhoff et al., 2005). Recent reports from Pimenta et al. (2013b) 
suggest that the N-terminal signal peptide adopts, immediately upon synthesis and 
while connected to the ribosome in the aqueous environment, an essentially random 
structure. Interaction with the SRP54M monomer then takes place. Upon binding, the 
signal peptide may then stabilize into a dynamic α-helical conformation, maintained 
within the hydrophobic environment of SRP54M, thus promoting its later binding to 
the endoplasmic reticulum translocator receptor. Conversely, observations in cells and 
tissues suggest that Doppel may also exist as an intracellular form devoid of the GPI 
anchor (Peoc’h et al., 2002; Cordier-Dirikoc et al., 2008). The existence of different 
Doppel forms either associated to the cell membrane via a GPI anchor, or in the intra- 
or extra-cellular spaces was proposed by Peoc’h and Laplanche (2006). Thus, a soluble 
form of Doppel protein was used during ovine sperm capacitation improving their 
motility, viability and fertilization rate (Pimenta et al., 2012a). The distribution as well 
as the function of both forms of Doppel protein may be species specific or related to 
spermatozoa quality and thus influencing their accessibility to antibodies and 
consequently the staining patterns. Also, Dpl contains a basic sequence at the N-
terminal (25-30) similar to the basic sequence (residues 23-28) found at the N-terminal 
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of PrPC (Papadopoulos et al., 2006) that resembles a nuclear localization sequence 
which in term may contribute to a certain degree of immunofluorescence antigen 
masking during nuclear uptake (Biverstahl et al., 2004; Pimenta et al., 2013b). 
Flow cytometry experiments were conducted with human and bovine mature 
ejaculated spermatozoa to successfully identify Doppel expression (Peoc’h et al., 2002; 
Rondena et al., 2005). Moreover, these last authors suggested an extensive application 
of this technique to animals with reduced fertility as a new parameter to consider 
during infertility studies. Therefore, in the present study flow cytometry was 
performed for two purposes: to quantify and differentiate ovine Doppel expression 
from animals with different PRND genotypes using both  fresh and FT semen, and to 
discriminate which of the two produced anti-Doppel monoclonal antibodies (M1 and 
M2) was  more specific for ovine Doppel detection. Regardless of the PRND genotype, 
we report here for the first time the differences of ovine Doppel detection between 
fresh (Fig. 14a) and FT (Fig. 14b) semen by using both M1 and M2 antibodies (P<0.03 
and P<0.05, respectively; Table 16). These observations strongly suggest that Doppel 
protein may suffer some conformational and biochemical alterations during the 
freezing process,  and are also consistent with the findings of Pimenta et al. (2012b), 
where a new developed anti-ovine Prt polyclonal antibody was unable to detect 
caprine Prt only due to subtle differences between ovine and goat Prt predicted 
tertiary structures. 
The use of FT semen for artificial insemination in sheep has not yet proved to be 
satisfactory. Indeed, artificial insemination is carried out mainly with chilled semen 
because of the low fertility results obtained when using FT semen in this species (Anel 
et al., 2005; Barbas et al., 2013b). The sperm plasma membrane is the primary site of 
damage induced by cryopreservation, but DNA damage and instability were also 
reported, effectively reducing the fertilization efficiency of the FT semen (Bailey et al., 
2000; Peris et al., 2007; Romão et al., 2013). Nevertheless, an individual variability 
among males for the susceptibility to the process of cryopreservation has been widely 
established (Hoffmann et al., 2011; Barbas et al., 2013a). Likewise, our results showed 
a decrease in Doppel expression after the ovine spermatozoa FT process (Table 16; Fig. 
14). Additionally, a greater Doppel mRNA abundance was detected in FT semen of 
bulls with high sire conception rate by Kasimanickam et al. (2012). Altogether, these 
results suggest that Doppel protein expression could be used to build a diagnostic tool 
to select males for improved cryoresistance and reproductive performance, or on the 
contrary, to identify the sub/infertile ones. 
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5. CONCLUSION 
In conclusion, presented data confirm that the identified polymorphisms in codon 26 
of ovine PRND gene are important for an improved semen cryoresistance and embryo 
production. Specifically the AA genotype should be actively selected in rams and PRND 
used as a candidate gene in breeding programs strategy. Three PRND polymorphisms 
were found for the first time in the human male Portuguese population. A linkage 
between codon 174 and 3’UTR polymorphisms of PRND gene was detected. Despite 
the small sample size, an enhanced viability after thawing and centrifugation in density 
gradients of post-thawed spermatozoa was observed in human male donors 
presenting CT genotype of codon 174 and TT genotype of 3’UTR polymorphism.  The 
relationship between these polymorphisms and male reproduction demands further 
studies. 
Furthermore the identification of Doppel protein in ovine ejaculated spermatozoa and 
its decrease expression after the cryopreservation process strongly suggests an 
important physiological function in male fertility, opening news insights to the 
possibility of male selection with improved cryoresistance and reproductive 
performance or towards the development of clinical treatment of infertility. 
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7. ANNEXES 
7.1. Annex I – culture media and solutions 
The following media are currently used in andrology and embryology laboratories in 
Animal Reproduction and Genetic Improvement Department at INIAV (Santarém, 
Portugal). 
Table 17 – MRF-SSCP denaturing solution 
Reagent Company Reference Concentration 
Formamide Invitrogen 15515-026 95% (w/v) 
NaOH Sigma-Aldrich S5881 10 mM 
Xylene cyanol Sigma-Aldrich X4126 0.05% (w/v) 
Bromophenol blue Sigma-Aldrich B0126 0.05% (w/v) 
 
Table 18 – Cryoprotective medium 
Reagent Company Reference Concentration Amount 
Trizma Base Sigma-Aldrich T1503 0.36 M 2.1805 g 
Citric Acid Merck 1.00244.1000 0.11 M 1.1880 g 
Glucose Sigma-Aldrich G6152 0.03 M 0.3000 g 
Egg yolk -- -- 15% (v/v) 8.0 mL 
Glycerol Merck 1.04091.1000 6.5% (v/v) 3.5 mL 
Antibiotics 
(sorocimicine) 
Laboratório 
Sorológico 
-- 0.1% (w/v) 0.0500 g 
H2O -- -- -- 38.0 mL 
 
Table 19 – Ovine swim-up and sperm capacitation medium 
Reagent Company Reference Concentration Amount 
NaCl Sigma-Aldrich S5886 0.12 M 0.3580 g 
KCl Sigma-Aldrich P9333 4 mM 0.0150 g 
NaHCO3 Merck 1.06329.0500 4 mM 0.0169 g 
NaH2PO4 H2O Sigma-Aldrich S9638 0.7 mM 0.0050 g 
MgCl2 6H2O Sigma-Aldrich M0250 0.5 mM 0.0053 g 
CaCl2 2H2O Sigma-Aldrich C5080 2 mM 0.0165 g 
Hepes Sigma-Aldrich H3375 0.01 M 0.1200 g 
Sodium pyruvate Sigma-Aldrich P4562 9 mM 0.0550 g 
BSA Sigma-Aldrich A7888 0.3% (w/v) 0.1500 g 
Glucose Sigma-Aldrich G6152 0.01 M 0.1250 g 
Sheep superovulated 
oestrus serum 1 
-- -- 20% (v/v) 8 mL 
H2O Sigma-Aldrich W1503 -- 40 mL 
1
 See sheep superovulated oestrus serum protocol. 
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Table 20 – CTC buffer solution 
Reagents Company Reference Concentration Amount 
NaCl Sigma-Aldrich S5886 0.04 M 0.240 g 
Tris Base Sigma-Aldrich T1503 0.06 M 0.760 g 
H2O -- -- -- 100 mL 
 
Table 21 – CTC staining solution 
Reagents Company Reference Concentration Amount 
Chlortetracycline Sigma-Aldrich 26430 0.8 mM 0.0020 g 
L-cysteine Merck  1.02838.0025 7 mM 0.0044 g 
CTC buffer solution -- -- -- 5 mL 
 
Table 22 – JC-1 incubation medium (adapted from Gamboa et al. (2010)) 
Reagents Company Reference Concentration Amount 
Hank's Balanced Salt solution Sigma-Aldrich H6648 -- 10 mL 
BSA Sigma-Aldrich A7888 1% (w/v) 0.1 g 
Hepes Sigma-Aldrich H3375 19.5 mM 0.0466 g 
JC-1 in DMSO Sigma-Aldrich T4069 8 nM 1 µL 
 
Table 23 – Synthetic oviduct fluid (SOF) medium 
Reagents Company Reference Concentration Amount 
NaCl Sigma-Aldrich S5886 0.11 M 0.3147 g 
KCl Sigma-Aldrich P9333 7 mM 0.0267 g 
KH2PO4 Merck 1.04873.0250 1 mM 0.0081 g 
CaCl2 2H2O Sigma-Aldrich C5080 2 mM 0.0126 g 
MgCl2 6H2O Sigma-Aldrich M0250 0.5 mM 0.0049 g 
NaHCO3 Merck 1.06329.0500 0.02 M 0.105 g 
Sodium lactate Merck 1.06522.2500 3 mM 14.1 µL 
Sodium pyruvate Sigma-Aldrich P4562 0.3 mM 0.0017 g 
Phenol red Sigma-Aldrich P3532 4 µM 0.000065 g 
L-Glutathione Sigma-Aldrich G6013 0.1 mM 0.00155 g 
L-Glutamine Sigma-Aldrich G8540 0.86 mM 0.25 mL 
BME amino acids 
solution 
Sigma-Aldrich B6766 2% 1 mL 
MEM non-essential 
amino acids solution 
Sigma-Aldrich M7145 1% 0.5 mL 
H2O Sigma-Aldrich W1503 -- 50 mL 
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Table 24 – Oocyte maturation medium 
Reagents Company Reference Concentration Amount 
Medium 199 Sigma-Aldrich M4530 -- 5 mL 
Gentamicine Sigma-Aldrich G1272 4 µLmL-1 20 µL 
Epidermal Growth Factor Sigma-Aldrich E4127 10 ngmL-1 50 µL 
Cysteamine Sigma-Aldrich M9768 0.08 mM 50 µL 
β-Estradiol Sigma-Aldrich E4389 10 µLmL-1 50 µL 
 
Table 25 – In vitro fertilization (IVF) medium 
Reagents Laboratory Reference Concentration Amount 
SOF medium -- -- -- 9 mL 
Sheep superovulated 
oestrus serum 1 
-- -- 10% (v/v) 1 mL 
Gentamicine Sigma-Aldrich G1272 4 µLmL-1 40 µL 
1
 See sheep superovulated oestrus serum protocol. 
 
Sheep superovulated oestrus serum protocol 
A sponge impregnated with progesterone was placed into ewe vagina (Day 0) and kept 
for 9 days. At Day 8, 24 hours before sponge removal, 150 µg of PGF2α plus 1500 IU of 
eCG were administrated to the ewe. Blood samples were collected 24-30 hs after 
sponge removal. Blood samples were placed at 4oC and serum manipulated 12-18 
hours after collection. 
 
Table 26 – Zygote transfer medium 
Reagents Company Reference Concentration Amount 
SOF medium -- -- -- 12.5 mL 
BSA Sigma-Aldrich A7888 0.6% 0.075 g 
 
Table 27 – In vitro embryo culture medium 
Reagents Company Reference Concentration Amount 
SOF medium -- -- -- 9 mL 
BSA Sigma-Aldrich A7888 0.6% 0.060 g 
Foetal bovine serum Sigma-Aldrich F9665 10% 1 mL 
 
  
70 
 
7.2. Annex II – oral presentations 
 
6th Veterinary Sciences Congress: Praxis and Future 
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Sperm capacitation status in fresh and cryopreserved ovine semen and 
its effect on in vitro embryo production 
Ferreira LM1, García-Herreros M2, Marques CC1, Barbas JP1, Baptista MC1, Horta AEM1, Pereira 
RMLN1,3  
 
1Unidade de Biotecnologia e Recursos Genéticos, Instituto Nacional de Investigação Agrária e Veterinária, Quinta da Fonte Boa, 
2005-048 Vale de Santarém, Portugal. 
2 Departamento de Medicina Veterinária, Faculdade de Zootecnia e Engenharia de Alimentos (FZEA), Universidade de São Paulo, 
Brasil. 
3Escola Universitária Vasco da Gama, Coimbra, Portugal. 
Ram semen cryopreservation causes functional damage to sperm which may impair its 
fertility. Capacitation status could be associated to sperm lifespan, and therefore, may 
be linked to the success during fertilization process. Nevertheless, there are different 
sperm properties such as biophysical changes that may be modified during the 
freezing-thawing process, contributing to the lower fertility of thawed semen. In this 
study we aim to identify the capacitation status and morphometrical alterations of 
both fresh and frozen-thawed sperm and its influence on fertilization ability and 
embryo production. Ejaculates from four rams were equally divided in two aliquots 
and used as fresh (Fsh) and cryopreserved (FT) samples for IVF process. Concentration, 
motility, viability, and sperm head morphometrical characteristics were analysed for 
Fsh and FT samples. Chlortetracycline staining (CTC) was performed in Fsh samples 
after collection, after 2 to 6 hours of incubation at room temperature, and after swim-
up; and in FT samples after thawing, and after swim-up. Three distinctive sperm 
populations were identified: non-capacitated (F), capacitated with intact acrosome (B), 
and acrosome reacted (AR). Mature cumulus-oocyte complexes were inseminated with 
Fsh or FT sperm samples after swim-up selection process. Eighteen hours pi, 
presumptive zygotes were cultured in synthetic oviductal fluid (SOF) enriched with 
aminoacids and bovine serum albumin (BSA) at 38.5 ºC, under 5% O2, 5% CO2 and 90% 
N2 until 2-to 8-cell embryo stage. After cleavage rate assessment, embryo 
development was carried out to blastocyst stage in SOF+BSA medium with 10% FCS. 
Our preliminary results showed that initial, pre- and post-swim-up motility, post-swim-
up concentration and vigour were superior in Fsh semen compared to FT samples 
(P<0.001). Before swim-up selection, Fsh sperm showed a higher F and a lower AR 
percentage than FT sperm (P<0.05). After swim-up, the percentage of sperm showing B 
pattern was higher in Fsh compared to FT samples (P<0.05). Regarding sperm head 
morphometry, dimensional (Area, Perimeter, Length and Width) and shape 
parameters (Ellipticity, Elongation and Rugosity) changed drastically after 
cryopreservation process (P<0.001). Embryo production rates were higher after 
insemination with Fsh semen (P<0.05). Our results indicate there is an important effect 
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of the freezing-thawing process on ram sperm motility, vigour, head morphometry and 
capacitation status with repercussion in fertilization and embryo production. 
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Cryotolerance of bovine oocytes: Is membrane permeability to water 
and cryoprotectants really important? 
Matos JE1, Marques CC2, Ferreira LM2, Baptista MC2, Horta AEM2, Moura T1, Soveral G1, Pereira 
RMLN2,3 
1 Faculdade de Farmácia. Universidade de Lisboa, Lisboa, Portugal. 
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Oocyte cryopreservation is increasingly in demand due to the need for preserving 
gametes of both humans and animals. This technique requires several steps during 
which cells must withstand extreme anisosmotic conditions and their associated cell 
volume fluxes. These volume excursions place a cumulative osmotic stress on the cell. 
Therefore the permeability of the plasma membrane to water and cryoprotectants is 
one of the important cryobiological properties affecting the survival of an oocyte after 
vitrification. Our goal was to determine and manipulate bovine oocyte membrane 
permeability to water and two cryoprotectants, ethylene glycol (EG) and dimethyl 
sulfoxide (DMSO), often used in oocyte cryopreservation protocols. Moreover their 
effects on oocyte post-thawed developmental competence were further determined. 
Abattoir derived bovine oocytes were cultured for 22- 24h with 100 μM trans10 cis12 
conjugated linoleic isomer (CLA) or without supplementation (CLA and control groups). 
Fresh mature oocytes were immobilized in glass slides coated, observed in an inverted 
microscope and the dynamic of oocyte volume changes quantified. To investigate 
oocyte permeability to water and cryoprotectants, two solutions containing 200 mM 
sucrose or 10% DMSO and 10% EG were used. Mature oocytes from both groups were 
vitrified using cryotop and warmed (4 sessions) prior to in vitro fertilization. Embryo 
culture proceeded in SOF supplemented medium. Results showed a significant CLA 
effect (p<0.001) on the osmotic water permeability: permeability in control oocytes 
was significantly higher (0.014 ± 0.002 cm.s-1; n=11) than in oocytes matured with CLA 
(0.010 ± 0.002 cm.s-1; n=11). Similar effect was observed on the cryoprotectants 
permeability (p<0.001). Moreover CLA improved (p<0.05) the developmental 
competence of frozen-thawed oocytes. In conclusion, CLA presence during maturation 
slowdown oocyte membrane permeability to water, DMSO and EG, although 
improving subsequent cryosurvival. Therefore a dichotomy between the membrane 
permeability to cryoprotectants and cryotolerance was identified in bovine oocytes. 
 
